Alle publicaties van Prof. dr. W. van den Brink MD PhD

2017

  • Achterbergh RCA, van der Helm JJ, van den Brink W, de Vries HJC, Design of a syndemic based intervention to facilitate care for men who have sex with men with high risk behaviour: the syn.bas.in randomized controlled trial. BMC INFECT DIS 2017;17 (1):398 [PubMed]
  • Beraha E, Bodewits P, van den Brink W, Wiers R, Speaking fluently with baclofen?. BMJ CASE REP 2017;ahead of print [PubMed]
  • Beraha EM, Salemink E, Goudriaan AE, van den Brink W, Wiers RW, Response to "Baclofen and alcohol use disorders: From miracle to mirage". EUR NEUROPSYCHOPHARM 2017;27 (7):693-694 [PubMed]
  • Caraci F, Enna SJ, Zohar J, Racagni G, Zalsman G, van den Brink W, Kasper S, Koob GF, Pariante CM, Piazza PV, Yamada K, Spedding M, Drago F, A new nomenclature for classifying psychotropic drugs. BRIT J CLIN PHARMACO 2017;83 (8):1614-1616 [PubMed]
  • Drost LM. Survivalkid(s): Online support for adolescents and young adults with a mentally ill family member. S.l.: s.n.; 2017. 155p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Schippers GM, van den Brink W; copromotor(s): van der Krieke JAJ, Sytema S)
  • Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R, Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. AM J PUBLIC HEALTH 2017;107 (8):E1-E12 [PubMed]
  • Fischer B, van den Brink W, Hall W, LeFoll B, Rehm J, Room R, Fischer et al. Respond. AM J PUBLIC HEALTH 2017;107 (12):e26-e27 [PubMed]
  • Gomes T. Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada. S.l.: s.n.; 2017. 262p. ISBN 9789402806984 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij St Michael's Hospital, Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada., -. (Promotor(s): van den Brink W, Juurlink DN; copromotor(s): )
  • Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W, Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLOS MED 2017;14 (10):e1002396 [PubMed]
  • Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W, Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada. DRUG ALCOHOL DEPEN 2017;179:416-423 [PubMed]
  • Kaag AM, van Wingen GA, Caan MWA, Homberg JR, van den Brink W, Reneman L, White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. ADDICT BIOL 2017;22 (4):1048-1056 [PubMed]
  • Koenders L, Lorenzetti V, de Haan L, Suo C, Vingerhoets W, van den Brink W, Wiers RW, Meijer CJ, Machielsen M, Goudriaan AE, Veltman DJ, Yücel M, Cousijn J, Longitudinal study of hippocampal volumes in heavy cannabis users. J PSYCHOPHARMACOL 2017;31 (8):1027-1034 [PubMed]
  • Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J, Moggi F, Ramos-Quiroga JA, Levin FR, Carpentier PJ, Skutle A, Bu ET, Kaye S, Demetrovics Z, Barta C, Auriecomb M, Fatséas M, Johnson B, Faraone SV, Allsop S, Carruthers S, Schoevers RA, Verspreet S, Dom G, Koeter MWJ, van den Brink W, Childhood trauma exposure in substance use disorder patients with and without ADHD. ADDICT BEHAV 2017;65:118-124 [PubMed]
  • Machielsen MWJ, Veltman DJ, van den Brink W, de Haan L, Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study. SCHIZOPHR RES 2017;ahead of print [PubMed]
  • Mattila T, Koeter M, Wohlfarth T, Storosum J, van den Brink W, Derks E, Leufkens H, Denys D, The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials. EUR NEUROPSYCHOPHARM 2017;27 (1):82-86 [PubMed]
  • Schipper R, Dekker M, de Haan L, van den Brink W, Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series. J PSYCHOPHARMACOL 2017;ahead of print [PubMed]
  • Schulte MHJ, Kaag AM, Wiers RW, Schmaal L, van den Brink W, Reneman L, Homberg JR, van Wingen GA, Goudriaan AE, Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. DRUG ALCOHOL DEPEN 2017;179:117-123 [PubMed]
  • Sjoerds Z, Stufflebeam SM, Veltman DJ, van den Brink W, Penninx BWJH, Douw L, Loss of brain graph network efficiency in alcohol dependence. ADDICT BIOL 2017;22 (2):523-534 [PubMed]
  • van Amsterdam J, van der Velde B, Schulte M, van den Brink W, Causal Factors of Increased Smoking in ADHD: A Systematic Review. SUBST USE MISUSE 2017;ahead of print [PubMed]
  • van den Brink W, ICD-11 Gaming Disorder: Needed and just in time or dangerous and much too early? Commentary on: Scholars' open debate paper on the World Health Organization ICD-11 Gaming Disorder proposal (Aarseth et al.). J BEHAV ADDICT 2017;6 (3):290-292 [PubMed]
  • van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Koeter MW, Schoevers RA, van den Brink W, Diagnosing ADHD during active substance use: Feasible or flawed?. DRUG ALCOHOL DEPEN 2017;180:371-375 [PubMed]

2016

  • Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest Dv, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW, Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial. EUR NEUROPSYCHOPHARM 2016;26 (12):1950-1959 [PubMed]
  • Blanken P, Hendriks VM, Huijsman IA, van Ree JM, van den Brink W, Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. DRUG ALCOHOL DEPEN 2016;164:55-63 [PubMed]
  • Cohn MD, van Lith K, Kindt M, Pape LE, Doreleijers TAH, van den Brink W, Veltman DJ, Popma A, Fear extinction, persistent disruptive behavior and psychopathic traits: fMRI in late adolescence. SOC COGN AFFECT NEUR 2016;11 (7):1027-1035 [PubMed]
  • Cohn MD, Viding E, McCrory E, Pape L, van den Brink W, Doreleijers TAH, Veltman DJ, Popma A, Regional grey matter volume and concentration in at-risk adolescents: Untangling associations with callous-unemotional traits and conduct disorder symptoms. PSYCHIAT RES-NEUROIM 2016;254:180-187 [PubMed]
  • Figee M, Pattij T, Willuhn I, Luigjes J, van den Brink W, Goudriaan A, Potenza MN, Robbins TW, Denys D, Compulsivity in obsessive-compulsive disorder and addictions. EUR NEUROPSYCHOPHARM 2016;26 (5):856-868 [PubMed]
  • Gevonden M, Myin-Germeys I, Wichers M, Booij J, van den Brink W, van Winkel R, Selten JP, Reactivity to social stress in ethnic minority men. PSYCHIAT RES 2016;246:629-636 [PubMed]
  • Jansen JM. Neurostimulation in alcohol dependence: The effect of repetitive transcranial magnetic stimulation on cognitive functioning and craving. S.l.: s.n.; 2016. 124p. ISBN 9789462954694 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Goudriaan AE, van den Brink W; copromotor(s): )
  • Kaag AM. Are cocaine users too sensitive? Functional and structural brain imaging studies in regular cocaine users. S.l.: s.n.; 2016. 121p. ISBN 9789462953727 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Reneman L; copromotor(s): van Wingen GA, Homberg JR)
  • Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G, Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. AM J PSYCHIAT 2016;173 (10):1033-1042 [PubMed]
  • Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA, Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. FRONT HUM NEUROSCI 2016;10:418 [PubMed]
  • Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MWJ, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W, Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. J ATTEN DISORD 2016;ahead of print [PubMed]
  • Kiefer F, van den Brink W, Gual A, Mann K, European Addiction Research Becomes the Official Journal of the European Federation of Addiction Societies. EUR ADDICT RES 2016;22 (1):I-II [PubMed]
  • Koenders L, Cousijn J, Vingerhoets WAM, van den Brink W, Wiers RW, Meijer CJ, Machielsen MWJ, Veltman DJ, Goudriaan AE, de Haan L, Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study. PLOS ONE 2016;11 (5):e0152482 [PubMed]
  • Kronenberg LM, Goossens PJJ, van Busschbach JT, van Achterberg T, van den Brink W, Burden and Expressed Emotion of Caregivers in Cases of Adult Substance Use Disorder with and Without Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder. INT J MENT HEALTH AD 2016;14 (1):49-63 [PubMed]
  • Luigjes J, Figee M, Tobler PN, van den Brink W, de Kwaasteniet B, van Wingen G, Denys D, Doubt in the Insula: Risk Processing in Obsessive-Compulsive Disorder. FRONT HUM NEUROSCI 2016;10:283 [PubMed]
  • Mann K, Torup L, Sørensen P, Gual A, Swift R, Walker B, van den Brink W, Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy. EUR NEUROPSYCHOPHARM 2016;26 (12):1941-1949 [PubMed]
  • Maraz A, Andó B, Rigó P, Harmatta J, Takách G, Zalka Z, Boncz I, Lackó Z, Urbán R, van den Brink W, Demetrovics Z, The two-faceted nature of impulsivity in patients with borderline personality disorder and substance use disorder. DRUG ALCOHOL DEPEN 2016;163:48-54 [PubMed]
  • Merkx MJM. Guidelines for patient treatment matching In the substance abuse treatment system: Feasibility, predictive validity and improvement. S.l.: s.n.; 2016. 205p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij Jellinek, Arkin, AIAR. (Promotor(s): Schippers GM, van den Brink W; copromotor(s): Koeter MWJ)
  • Nuijten M, Blanken P, van den Brink W, Goudriaan AE, Hendriks VM, Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial. J PSYCHOPHARMACOL 2016;30 (7):616-626 [PubMed]
  • Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W, Hendriks VM, Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. LANCET 2016;387 (10034):2226-2234 [PubMed]
  • Randesi M, van den Brink W, Levran O, Blanken P, Butelman ER, Yuferov V, da Rosa JC, Ott J, van Ree JM, Kreek MJ, Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. DRUG ALCOHOL DEPEN 2016;168:164-169 [PubMed]
  • Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R, Treatment Seeking for Alcohol Use Disorders: Treatment Gap or Adequate Self-Selection?. EUR ADDICT RES 2016;22 (5):277-285 [PubMed]
  • van Amsterdam JGC, Brunt TM, McMaster MTB, Niesink R, van den Brink W. Neurotoxicity due to repeated comas following excessive use of GHB in: Preedy VR, editors. Neuropathology of Drug Addictions and Substance Misuse Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. S.l.: Academic Press; 2016., p. -
  • Vingerhoets WAM, Koenders L, van den Brink W, Wiers RW, Goudriaan AE, van Amelsvoort T, de Haan L, Cousijn J, Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later. J PSYCHOPHARMACOL 2016;30 (2):152-158 [PubMed]
  • Welten CCM, Koeter MWJ, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HGM, Denys DAJP, Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis. J CLIN PSYCHOPHARM 2016;36 (1):71-76 [PubMed]
  • Welten CCM, Koeter MWJ, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HGM, Denys DAJP, Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis. J CLIN PSYCHIAT 2016;77 (9):e1117-e1123 [PubMed]
  • Zandi T, Havenaar JM, Laan W, Kahn RS, van den Brink W, Effects of a culturally sensitive assessment on symptom profiles in native Dutch and Moroccan patients with a first psychosis referral. TRANSCULT PSYCHIATRY 2016;53 (1):45-59 [PubMed]

2015

  • Benschop A, Liebregts N, van der Pol P, Schaap R, Buisman R, van Laar M, van den Brink W, de Graaf R, Korf DJ, Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence. ADDICT BEHAV 2015;40:91-95 [PubMed]
  • Bongers P, van de Giessen E, Roefs A, Nederkoorn C, Booij J, van den Brink W, Jansen A, Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. HEALTH PSYCHOL 2015;34 (6):677-685 [PubMed]
  • Cohn MD, Pape LE, Schmaal L, van den Brink W, van Wingen G, Vermeiren RRJM, Doreleijers TAH, Veltman DJ, Popma A, Differential relations between juvenile psychopathic traits and resting state network connectivity. HUM BRAIN MAPP 2015;36 (6):2396-2405 [PubMed]
  • Cohn MD, Veltman DJ, Pape LE, van Lith K, Vermeiren RRJM, van den Brink W, Doreleijers TAH, Popma A, Incentive Processing in Persistent Disruptive Behavior and Psychopathic Traits: A Functional Magnetic Resonance Imaging Study in Adolescents. BIOL PSYCHIAT 2015;78 (9):615-624 [PubMed]
  • Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G, Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. HUM BRAIN MAPP 2015;36 (10):4222-4230 [PubMed]
  • Fischer B, Kuganesan S, Gallassi A, Malcher-Lopes R, van den Brink W, Wood E, Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use. INT J DRUG POLICY 2015;26 (12):1177-1182 [PubMed]
  • Gevonden MJ, Myin-Germeys I, van den Brink W, van Os J, Selten JP, Booij J, Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment. PSYCHOL MED 2015;45 (8):1665-1674 [PubMed]
  • Heytens L, Neels H, van Regenmortel N, van den Brink W, Henckes M, Schouwers S, Dockx G, Crunelle CL, Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication. ANN CLIN BIOCHEM 2015;52 (Part 2):283-287 [PubMed]
  • Houwert-Steins Bisschop CN, Zantvoord JB , Machielsen MWJ, Koeter M, van den Brink W, 'Dosisreductiestrategie in plaats van onderhouds-behandeling na eerste psychose: op lange termijn tweemaal zo vaak herstel' Houwert-Steins Bisschop e.a. TIJDSCHR PSYCHIATR 2015;57 (4):305-308 [PubMed]
  • Jansen JM, van Holst RJ, van den Brink W, Veltman DJ, Caan MWA, Goudriaan AE, Brain function during cognitive flexibility and white matter integrity in alcohol-dependent patients, problematic drinkers and healthy controls. ADDICT BIOL 2015;20 (5):979-989 [PubMed]
  • Jansen JM, van Wingen G, van den Brink W, Goudriaan AE, Resting state connectivity in alcohol dependent patients and the effect of repetitive transcranial magnetic stimulation. EUR NEUROPSYCHOPHARM 2015;25 (12):2230-2239 [PubMed]
  • Koenders L, Machielsen MWJ, van der Meer FJ, van Gasselt ACM, Meijer CJ, van den Brink W, Koeter MWJ, Caan MWA, Cousijn J, den Braber A, van 't Ent D, Rive MM, Schene AH, van de Giessen E, Huyser C , de Kwaasteniet BP, Veltman DJ, de Haan L, Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. J PSYCHIATR NEUROSCI 2015;40 (3):197-206 [PubMed]
  • Kronenberg L. Dealing with SUD and co-occurring AHDH or ASD. A study to inform better care for patients and caregivers. Nijmegen: s.n.; 2015. -p. Proefschrift Radboud Universiteit Nijmegen, -. (Promotor(s): van Achterberg T, van den Brink W; copromotor(s): Goossens P)
  • Kronenberg LM, Goossens PJJ, van Busschbach J, van Achterberg T, van den Brink W, Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). BMC PSYCHIATRY 2015;15:159 [PubMed]
  • Kronenberg LM, Goossens PJJ, van Etten DM, van Achterberg T, van den Brink W, Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). PERSPECT PSYCHIATR C 2015;51 (1):4-15 [PubMed]
  • Kronenberg LM, Verkerk-Tamminga R, Goossens PJJ, van den Brink W, van Achterberg T, Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). ARCH PSYCHIAT NURS 2015;29 (4):242-248 [PubMed]
  • Liebregts N. Cannabis changes: Understanding dynamics of use and dependence. Amsterdam: s.n.; 2015. -p. Proefschrift UvA, niet faculteit geneeskunde. (Promotor(s): Korf D, van den Brink W; copromotor(s): de Graaf R, van Laar M)
  • Liebregts N, van der Pol P, de Graaf R, van Laar M, van den Brink W, Korf DJ, Persistence and desistance in heavy cannabis use: the role of identity, agency, and life events. J YOUTH STUD 2015;18 (5):617-633
  • Liebregts N, van der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ, The role of leisure and delinquency in frequent cannabis use and dependence trajectories among young adults. INT J DRUG POLICY 2015;26 (2):143-152 [PubMed]
  • Luigjes J. Out of control: Losing oneself in compulsivity. S.l.: s.n.; 2015. 219p. ISBN 978-94-6295-215-7 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Denys DAJP, van den Brink W; copromotor(s): van Wingen GA)
  • Luigjes J, van den Brink W, Schuurman PR, Kuhn J, Denys D, Is deep brain stimulation a treatment option for addiction?. ADDICTION 2015;110 (4):547-548 [PubMed]
  • Maraz A, van den Brink W, Demetrovics Z, Prevalence and construct validity of compulsive buying disorder in shopping mall visitors. PSYCHIAT RES 2015;228 (3):918-924 [PubMed]
  • Mattila T, Koeter M, Wohlfarth T, Storosum J, van den Brink W, de Haan L, Derks E, Leufkens H, Denys D, Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. SCHIZOPHRENIA BULL 2015;41 (3):637-643 [PubMed]
  • Nuijten M, Blanken P, van den Brink W, Hendriks V, Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial. J PSYCHOPHARMACOL 2015;29 (6):678-687 [PubMed]
  • Nutt DJ, Rehm J, van den Brink W, Gorwood P, Buchsbaum MS, Progress in mind: focus on alcohol use disorders, an elsevier resource centre. PSYCHIAT RES 2015;226 (2-3):513-514 [PubMed]
  • Ortal S, van de Glind G, Johan F, Itai B, Nir Y, Iliyan I, van den Brink W, The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review. CURR DRUG ABUSE REV 2015;8 (2):119-133 [PubMed]
  • Pape LE, Cohn MD, Caan MWA, van Wingen G, van den Brink W, Veltman DJ, Popma A, Psychopathic traits in adolescents are associated with higher structural connectivity. PSYCHIAT RES 2015;233 (3):474-480 [PubMed]
  • Sizoo BB, van der Gaag RJ, van den Brink W, Temperament and character as endophenotype in adults with autism spectrum disorders or attention deficit/hyperactivity disorder. AUTISM 2015;19 (4):400-408 [PubMed]
  • Skutle A, Bu ETH, Jellestad FK, Koeter MWJ, van den Brink W, Moggi F, Møller M, van den Glind G, Early developmental, temperamental and educational problems in ‘substance use disorder’ patients with and without ADHD. Does ADHD make a difference?. ADDICT BEHAV REP 2015;2:13-18
  • Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, Metrebian N, Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. BRIT J PSYCHIAT 2015;207 (1):5-14 [PubMed]
  • Stringer S, Cerrone KC, van den Brink W, van den Berg JF, Denys D, Kahn RS, Derks EM, A guide on gene prioritization in studies of psychiatric disorders. INT J METH PSYCH RES 2015;24 (4):245-256 [PubMed]
  • Tuithof M. Drinking Distilled. Onset, course and treatment of alcohol use disorders in the general population. S.l.: s.n.; 2015. 166p. ISBN 978-90-5253-758-0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Vollebergh WAM; copromotor(s): ten Have ML, de Graaf R)
  • Uhl A, Hunt G, van den Brink W, Stimson GV, How credible are international databases for understanding substance use and related problems?. INT J DRUG POLICY 2015;26 (2):119-121 [PubMed]
  • van Amsterdam J, Brunt T, van den Brink W, The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. J PSYCHOPHARMACOL 2015;29 (3):254-263 [PubMed]
  • van Amsterdam JGC, Wartenberg HHC, van den Brink W, Forse toename voorgeschreven opioïden in Nederland. NED TIJDSCHR GENEESKD 2015;159:A9245 [PubMed]
  • van Amsterdam J, Nabben T, van den Brink W, Recreational nitrous oxide use: Prevalence and risks. REGUL TOXICOL PHARM 2015;73 (3):790-796 [PubMed]
  • van Amsterdam J, Nutt D, Phillips L, van den Brink W, European rating of drug harms. J PSYCHOPHARMACOL 2015;29 (6):655-660 [PubMed]
  • van Amsterdam J, Phillips L, Henderson G, Bell J, Bowden-Jones O, Hammersley R, Ramsey J, Taylor P, Dale-Perera A, Melichar J, van den Brink W, Nutt D, Ranking the harm of non-medically used prescription opioids in the UK. REGUL TOXICOL PHARM 2015;73 (3):999-1004 [PubMed]
  • van Amsterdam J, van den Brink W, The Misuse of Prescription Opioids: A Threat for Europe?. CURR DRUG ABUSE REV 2015;8 (1):3-14 [PubMed]
  • van den Berg JF, van den Brink W, Kist N, Hermes JSJ, Kok RM, Social factors and readmission after inpatient detoxification in older alcohol-dependent patients. AM J ADDICTION 2015;24 (7):661-666 [PubMed]
  • van den Brink W. Alcoholverslaving te behandelen door de huisarts in: Bindels PJ, Berg PJ, van den Brink A , van der Lelij A, de Vries AD, editors. Ontwikkelingen in de Geneeskunde 2015. Rotterdam: Erasmus MC; 2015., p. -
  • van den Brink W, De multidisciplinaire richtlijn opiaatverslaving. PSYFAR 2015;10:10-16
  • van den Brink W, Substance use disorders, trauma, and PTSD. EUR J PSYCHOTRAUMATO 2015;6 (1):27632
  • van den Brink W, Strang J, Gual A, Sørensen P, Jensen TJ, Mann K, Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme. EXPERT OPIN DRUG SAF 2015;14 (4):495-504 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, Three-Year Course of Cannabis Dependence and Prediction of Persistence. EUR ADDICT RES 2015;21 (6):279-290 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, Wel of geen hulp zoeken voor cannabisafhankelijkheid?. VERSLAVING 2015;11 (2):103-115
  • van der Vorst L, van den Brink W, Doedens P, Farmacotherapie bij de behandeling van stoornissen in het gebruik van alcohol, drugs en gokken. NURSE ACADEMY GGZ 2015;2015 (3):24-29
  • van Emmerik-van Oortmerssen K, Vedel E, van den Brink W, Schoevers RA, Integrated cognitive behavioral therapy for patients with substance use disorder and comorbid ADHD: two case presentations. ADDICT BEHAV 2015;45:214-217 [PubMed]
  • Vorspan F, Fortias M, Zerdazi EH, Karsinti E, Bloch V, Lépine JP, Bellivier F, Brousse G, van den Brink W, Derks EM, Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence. AM J ADDICTION 2015;24 (8):740-743 [PubMed]
  • Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MWJ, van den Brink W, Moggi F, Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. EUR ADDICT RES 2015;21 (4):188-194 [PubMed]
  • Welten CCM, Koeter MWJ, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HGM, Denys DAJP, Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies. J PSYCHOPHARMACOL 2015;29 (8):923-932 [PubMed]
  • Welten CCM, Koeter MWJ, Wohlfarth TD, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HGM, Denys DAJP, Net gain analysis, an addition to responder analysis - The case of antipsychotic treatment of acute mania. REGUL TOXICOL PHARM 2015;73 (1):227-231 [PubMed]
  • Welten CCM, Koeter MWJ, Wohlfarth T, Storosum JG, van den Brink W, Gispen-de Wied CC, Leufkens HGM, Denys DAJP, Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysis. EUR NEUROPSYCHOPHARM 2015;25 (7):1018-1026 [PubMed]
  • Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D, Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. DRUG ALCOHOL REV 2015;34 (6):683-693 [PubMed]
  • Zaaijer ER. Chasing the dragon away: Personality as a protective factor and extended-release naltrexone as a treatment for heroin dependence. S.l.: s.n.; 2015. 117p. ISBN 978-94-6182-577-3 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Booij J, van den Brink W; copromotor(s): Goudriaan AE)
  • Zaaijer ER, de Bruin K, la Fleur SE, Goudriaan AE, van den Brink W, Booij J, Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats. J PSYCHOPHARMACOL 2015;29 (3):344-348 [PubMed]
  • Zaaijer ER, van Dijk L, de Bruin K, Goudriaan AE, Lammers LA, Koeter MWJ, van den Brink W, Booij J, Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients. PSYCHOPHARMACOLOGY 2015;232 (14):2597-2607 [PubMed]

2014

  • Boschloo L, van den Brink W, Penninx BWJH, Does self-medication predict the persistence or rather the recurrence of alcohol dependence?. JAMA PSYCHIAT 2014;71 (2):205 [PubMed]
  • Brunt TM, van Amsterdam JGC, van den Brink W, GHB, GBL and 1,4-BD addiction. CURR PHARM DESIGN 2014;20 (25):4076-4085 [PubMed]
  • Cousijn J, Vingerhoets WAM, Koenders L, de Haan L, van den Brink W, Wiers RW, Goudriaan AE, Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls. ADDICT BIOL 2014;19 (2):282-293 [PubMed]
  • Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE, Effect of baseline cannabis use and working-memory network function on changes in cannabis use in heavy cannabis users: a prospective fMRI study. HUM BRAIN MAPP 2014;35 (5):2470-2482 [PubMed]
  • Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W, Reduced frontal brain volume in non-treatment-seeking cocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. FRONT HUM NEUROSCI 2014;8:7 [PubMed]
  • Crunelle CL, van den Brink W, Dom G, Booij J, Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD. BRIT J PSYCHIAT 2014;204 (6):486-487 [PubMed]
  • Derks EM, Vink JM, Willemsen G, van den Brink W, Boomsma DI, Genetic and environmental influences on the relationship between adult ADHD symptoms and self-reported problem drinking in 6024 Dutch twins. PSYCHOL MED 2014;44 (12):2673-2683 [PubMed]
  • Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, van Wingen G, de Kwaasteniet B, Mantione M, Ooms P, de Koning P, Vulink N, Levar N, Droge L, van den Munckhof P, Schuurman PR, Nederveen A, van den Brink W, Mazaheri A, Vink M, Denys D, Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder (vol 16, pg 386, 2013). NAT NEUROSCI 2014;17 (9):1286 [PubMed]
  • Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP, Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. JAMA PSYCHIAT 2014;71 (12):1364-1372 [PubMed]
  • Jansen JM, van den Heuvel OA, van der Werf YD, de Wit SJ, Veltman DJ, van den Brink W, Goudriaan AE, Niet-invasieve hersenstimulatie bij verslaving; het effect op craving en emotieregulatie. NEUROPRAXIS 2014;19 (3):54-59
  • Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L, Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. DRUG ALCOHOL DEPEN 2014;144:210-217 [PubMed]
  • Kaye S, Gilsenan J, Young JT, Carruthers S, Allsop S, Degenhardt L, van de Glind G, van den Brink W, Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. DRUG ALCOHOL DEPEN 2014;144:70-77 [PubMed]
  • Kräplin A, Bühringer G, Oosterlaan J, van den Brink W, Goschke T, Goudriaan AE, Dimensions and disorder specificity of impulsivity in pathological gambling. ADDICT BEHAV 2014;39 (11):1646-1651 [PubMed]
  • Kronenberg LM, Slager-Visscher K, Goossens PJJ, van den Brink W, van Achterberg T, Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective. BMC PSYCHIATRY 2014;14 (1):264 [PubMed]
  • Machielsen MWJ. Schizophrenia and comorbid cannabis use disorders. Brain structure, function and the effect of antipsychotic medications. s.l.: s.n.; 2014. 245p. ISBN 9789088918131 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): de Haan L, Veltman DJ; copromotor(s): van den Brink W)
  • Machielsen MWJ, Veltman DJ, van den Brink W, de Haan L, The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study. J PSYCHOPHARMACOL 2014;28 (7):633-642 [PubMed]
  • Matthys F, Joostens P, van den Brink W, Sabbe B, ADHD bij verslaafden: richtlijn voor de diagnostiek en de behandeling. TIJDSCHR GENEESKD 2014;70 (18):1065-1069
  • Matthys F, Soyez V, van den Brink W, Joostens P, Tremmery S, Sabbe B, Barriers to implementation of treatment guidelines for ADHD in adults with substance use disorder. J DUAL DIAGN 2014;10 (3):130-138 [PubMed]
  • Matthys F, Stes S, van den Brink W, Joostens P, Mobius D, Tremmery S, Sabbe B, Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders. INT J MENT HEALTH AD 2014;12 (5):629-647
  • Mattila T, Wohlfarth T, Koeter M, Storosum J, van den Brink W, de Haan L, Leufkens H, Denys D, Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia - an individual patient data meta-analysis. EUR NEUROPSYCHOPHARM 2014;24 (7):1067-1077 [PubMed]
  • Merkx MJM, Schippers GM, Koeter MWJ, de Wildt WAJM, Vedel E, Goudriaan AE, van den Brink W, Treatment outcome of alcohol use disorder outpatients with or without medically assisted detoxification. J STUD ALCOHOL DRUGS 2014;75 (6):993-998 [PubMed]
  • Nuijten M, Blanken P, van den Brink W, Hendriks V, Acceptatie en effectiviteit van topiramaat in de behandeling van cocaïneafhankelijkheid. TIJDSCHR PSYCHIATR 2014;56:617-618
  • Nuijten M, Blanken P, van den Brink W, Hendriks V, Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. DRUG ALCOHOL DEPEN 2014;138:177-184 [PubMed]
  • Romanczuk-Seiferth N, van den Brink W, Goudriaan AE, From symptoms to neurobiology: pathological gambling in the light of the new classification in DSM-5. NEUROPSYCHOBIOLOGY 2014;70 (2):95-102 [PubMed]
  • Roozen HG, Strietman M, Wiersema H, Meyers RJ, Lewinsohn PM, Feij JA, Greeven PGJ, Vingerhoets AJJM, van den Brink W, Engagement of pleasant activities in patients with substance use disorders: a correlational study. SUBST ABUS 2014;35 (3):254-261 [PubMed]
  • Schmaal L, Goudriaan AE, Joos L, Dom G, Pattij T, van den Brink W, Veltman DJ, Neural substrates of impulsive decision making modulated by modafinil in alcohol-dependent patients. PSYCHOL MED 2014;44 (13):2787-2798 [PubMed]
  • Schulte MHJ, Cousijn J, den Uyl TE, Goudriaan AE, van den Brink W, Veltman DJ, Schilt T, Wiers RW, Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. CLIN PSYCHOL REV 2014;34 (7):531-550 [PubMed]
  • Sjoerds Z, Luigjes J, van den Brink W, Denys D, Yücel M, The role of habits and motivation in human drug addiction: a reflection. FRONT PSYCHIATRY 2014;5:8 [PubMed]
  • Sjoerds Z, van den Brink W, Beekman ATF, Penninx BWJH, Veltman DJ, Cue reactivity is associated with duration and severity of alcohol dependence: an FMRI study. PLOS ONE 2014;9 (1):e84560 [PubMed]
  • Sjoerds Z, van den Brink W, Beekman ATF, Penninx BWJH, Veltman DJ, Response inhibition in alcohol-dependent patients and patients with depression/anxiety: a functional magnetic resonance imaging study. PSYCHOL MED 2014;44 (8):1713-1725 [PubMed]
  • Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R, Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder. DRUG ALCOHOL DEPEN 2014;140:85-91 [PubMed]
  • Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R, The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5. ALCOHOL CLIN EXP RES 2014;38 (1):249-256 [PubMed]
  • van Amsterdam J, Brunt T, Pennings E, van den Brink W, Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. REGUL TOXICOL PHARM 2014;70 (2):507-513 [PubMed]
  • van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J, Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. J PSYCHOPHARMACOL 2014;28 (9):866-873 [PubMed]
  • van de Giessen E, McIlwrick S, Veltman D, van den Brink W, Booij J. Obesity an addiction? Imaging of neurotransmitter systems in obesity in: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, den Boer JA, editors. PET and SPECT in psychiatry. Berlin; Heidelberg: Springer; 2014., p. 641-656
  • van de Glind G, Konstenius M, Koeter MWJ, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W [Contributors: Løvaas EK, Lossius K, van Wamel A, Bosma G, Hay D, Malivert M, Debrabant R, Dahl T, Stevens L, Roncero C, Daigre C, van der Gaag RJ, Cassar J, Young J]] , Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. DRUG ALCOHOL DEPEN 2014;134:158-166 [PubMed]
  • van den Berg JF, Hermes JSJ, van den Brink W, Blanken P, Kist N, Kok RM, Physical and mental health and social functioning in older alcohol-dependent inpatients: the role of age of onset. EUR ADDICT RES 2014;20 (5):226-232 [PubMed]
  • van den Brink W. Toekomst van de behandeling van verslaving en de rol van cognitieve gedragstherapie in: Schippers GM, Smeerdijk M, Merx MJM, editors. Handboek cognitieve gedragstherapie bij middelengebruik en gokken. Utrecht: Perspectief Uitgevers; 2014., p. 428-437
  • van den Brink W, Verslavingsgedrag van DSM-IV naar DSM-5. TIJDSCHR PSYCHIATR 2014;56 (3):206-210 [PubMed]
  • van den Brink W, Mann K, Gual A, Aubin HJ, Wim van den Brink and colleagues reply to Des Spence and Alain Braillon. BMJ-BRIT MED J 2014;348:g2605 [PubMed]
  • van den Brink W, Sørensen P, Torup L, Mann K, Gual A, Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. J PSYCHOPHARMACOL 2014;28 (8):733-744 [PubMed]
  • van der Meer FJ, Meijer JH, Meijer CJ, van den Brink W, Velthorst E [Contributors: Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I]] , Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls. PSYCHOL MED 2014;44 (9):1901-1911 [PubMed]
  • van der Pol P. The dynamics of cannabis use and dependence. s.l.: s.n.; 2014. -p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Korf DJ; copromotor(s): van Laar M, de Graaf R)
  • van der Pol P, Liebregts N, Brunt T, van Amsterdam J, de Graaf R, Korf DJ, van den Brink W, van Laar M, Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. ADDICTION 2014;109 (7):1101-1109 [PubMed]
  • van Emmerik-van Oortmerssen K, van de Glind G, Koeter MWJ, Allsop S, Auriacombe M, Barta C, Bu ETH, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S, van den Brink W, Schoevers RA [Contributors: Beniwal A, Bosma G, Cassar J, Dahl T, Daigre C, Debrabant R, Degenhardt L, van der Gaag RJ, Hay D, Lossius K, Løvaas EK, Malivert M, Möller M, Roncero C, Stevens L, Wallhed S, van Wamel A, Young J]] , Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. ADDICTION 2014;109 (2):262-272 [PubMed]
  • Vanes LD, van Holst RJ, Jansen JM, van den Brink W, Oosterlaan J, Goudriaan AE, Contingency learning in alcohol dependence and pathological gambling: learning and unlearning reward contingencies. ALCOHOL CLIN EXP RES 2014;38 (6):1602-1610 [PubMed]
  • van Holst RJ, Clark L, Veltman DJ, van den Brink W, Goudriaan AE, Enhanced striatal responses during expectancy coding in alcohol dependence. DRUG ALCOHOL DEPEN 2014;142:204-208 [PubMed]
  • van Zaane J, van de Ven PM, Draisma S, Smit JH, Nolen WA, van den Brink W, Effect of alcohol use on the course of bipolar disorder: one-year follow-up study using the daily prospective Life Chart method. BIPOLAR DISORD 2014;16 (4):400-409 [PubMed]
  • Zaaijer ER, Bruijel J, Blanken P, Hendriks V, Koeter MWJ, Kreek MJ, Booij J, Goudriaan AE, van Ree JM, van den Brink W, Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. DRUG ALCOHOL DEPEN 2014;145:101-105 [PubMed]
  • Zandi T. The role of cultural background in diagnosing psychotic disorders. Misclassification of psychiatric symptoms in Moroccan immigrants in the Netherlands. s.l.: s.n.; 2014. 157p. ISBN 9789088918025 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Kahn RS; copromotor(s): Havenaar JM)

2013

  • Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman ATF, Penninx BWJH, The role of negative emotionality and impulsivity in depressive/anxiety disorders and alcohol dependence. PSYCHOL MED 2013;43 (6):1241-1253 [PubMed]
  • Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman ATF, Penninx BWJH, Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA). J CLIN PSYCHIAT 2013;74 (12):1233-1240 [PubMed]
  • Braakman MH. Posttraumatic stress disorder with secondary psychotic features. A diagnostic validity study among refugees in the Netherlands. s.l.: s.n.; 2013. -p. Proefschrift Radboud Universiteit Nijmegen, Faculteit Geneeskunde. (Promotor(s): Kortmann FAM, van den Brink W; copromotor(s): Verkes RJ, Koeter MWJ)
  • Brunt TM, Koeter MW, Hertoghs N, van Noorden MS, van den Brink W, Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. DRUG ALCOHOL DEPEN 2013;131 (3):316-319 [PubMed]
  • Cohn MD, Popma A, van den Brink W, Pape LE, Kindt M, van Domburgh L, Doreleijers TAH, Veltman DJ, Fear conditioning, persistence of disruptive behavior and psychopathic traits: an fMRI study. TRANSL PSYCHIAT 2013;3:e319 [PubMed]
  • Corazza O, Demetrovics Z, van den Brink W, Schifano F, 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. INT J DRUG POLICY 2013;24 (1):82-83 [PubMed]
  • Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW, Neural responses associated with cue-reactivity in frequent cannabis users. ADDICT BIOL 2013;18 (3):570-580 [PubMed]
  • Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Porrino LJ, Goudriaan AE, Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. ADDICT BIOL 2013;18 (6):1013-1023 [PubMed]
  • Crunelle CL, van de Giessen E, Schulz S, Vanderschuren LJMJ, de Bruin K, van den Brink W, Booij J, Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability. ADDICT BIOL 2013;18 (6):908-911 [PubMed]
  • Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J, Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. EUR NEUROPSYCHOPHARM 2013;23 (12):1714-1723 [PubMed]
  • Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W, Impulsivity in adult ADHD patients with and without cocaine dependence. DRUG ALCOHOL DEPEN 2013;129 (1-2):18-24 [PubMed]
  • Derks EM, van den Brink W, Verslaving en erfelijkheid. VERSLAVING 2013;9 (2):70-72
  • Dom G, Schellekens A, Oude Voshaar R, van den Brink W, Verslavingsonderzoek in de Lage Landen leeft!. TIJDSCHR PSYCHIATR 2013;55 (11):817-819 [PubMed]
  • Dom G, van den Brink W, Ontwikkelingen in de farmacotherapie: geïndividualiseerde farmacotherapie?. TIJDSCHR PSYCHIATR 2013;55 (11):899-906 [PubMed]
  • Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, van Wingen G, de Kwaasteniet B, Mantione M, Ooms P, de Koning P, Vulink N, Levar N, Droge L, van den Munckhof P, Schuurman PR, Nederveen A, van den Brink W, Mazaheri A, Vink M, Denys D, Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. NAT NEUROSCI 2013;16 (4):386-387 [PubMed]
  • Fineberg NA, Baldwin DS, Menchon JM, Denys D, Grünblatt E, Pallanti S, Stein DJ, Zohar J [Contributors: Alonso P, Andreewitch S, Baldwin D, Bellodi L, Bersani G, Cath D, Chamberlain S, Clark L, Craig K, Denys D, dell'Osso B, Eilam D, Fineberg N, Goudriaan Anna E, Grünblatt E, Hermesh H, Heyman I, Hollander E, Hranov G, Hranov L, Ivarsson T, Joel D, Matthews K, Lochner C, Marazziti D, Mataix-Cols D, Menchon J, Noldus L, Pallanti S, Robbins T, Romanos M, Renner T, Rück C, Sahakian B, Stein D, van den Brink W, van den Heuvel O, van der Wee N, Veltman D, Walitza S, Zohar J]] , Manifesto for a European research network into obsessive-compulsive and related disorders. EUR NEUROPSYCHOPHARM 2013;23 (7):561-568 [PubMed]
  • Goudriaan AE, Veltman DJ, van den Brink W, Dom G, Schmaal L, Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI. ADDICT BEHAV 2013;38 (2):1509-1517 [PubMed]
  • Gual A, He Y, Torup L, van den Brink W, Mann K [Contributors: Domken MA, Geerts S, Matthys F, Peuskens H, de Nayer A, van den Ameele H, Gazziano A, Drahozal J, Solle Z, Syrovatka J, Loiseau T, Herve JP, Reynaud M, Louvrier J, Khalifa P, Modavi D, Grabli F, Fontbonne DP, Batel P, Mhiri R, Gailledreau J, Paille F, Perney P, Peyron E, Dally S, Bendimerad P, Aubin HJ, Ceccanti M, Fertonani-Affini G, Addolorato G, Patussi V, Lancia U, Zoli G, Janiri L, del Re A, Serretti A, Montesano F, Samochowiec J, Koston-Medrala D, Bogacki P, Perucki M, Badzio-Jagiello H, Malicki D, Domanski M, Ismail FA, Lara E, Rosa FM, Neto MG, Short A, Bobes J, Viciano MAB, Gual A, Galvez BP, Torrens M, Serecigni JG, Ochoa E, Martin MF, de la Gandara J]] , A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. EUR NEUROPSYCHOPHARM 2013;23 (11):1432-1442 [PubMed]
  • Jansen JM, Daams JG, Koeter MWJ, Veltman DJ, van den Brink W, Goudriaan AE, Effects of non-invasive neurostimulation on craving: a meta-analysis. NEUROSCI BIOBEHAV R 2013;37 (10 Part 2):2472-2480 [PubMed]
  • Joos L, Goudriaan AE, Schmaal L, de Witte NAJ, van den Brink W, Sabbe BGC, Dom G, The relationship between impulsivity and craving in alcohol dependent patients. PSYCHOPHARMACOLOGY 2013;226 (2):273-283 [PubMed]
  • Joos L, Goudriaan AE, Schmaal L, Fransen E, van den Brink W, Sabbe BGC, Dom G, Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. EUR NEUROPSYCHOPHARM 2013;23 (8):948-955 [PubMed]
  • Joos L, Goudriaan AE, Schmaal L, van den Brink W, Sabbe BGC, Dom G, Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial. J PSYCHOPHARMACOL 2013;27 (11):998-1006 [PubMed]
  • Joos L, Schmaal L, Goudriaan AE, Fransen E, van den Brink W, Sabbe BGC, Dom G, Age of onset and neuropsychological functioning in alcohol dependent inpatients. ALCOHOL CLIN EXP RES 2013;37 (3):407-416 [PubMed]
  • Kuyck WGE, de Beurs E, Barendregt M, van den Brink W, Psychometric Evaluation of the Dutch Version of the Impulsive/Premeditated Aggression Scale (IPAS) in Male and Female Prisoners. INT J FORENSIC MENT 2013;12 (3):172-179
  • Liebregts N, van der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ, The Role of Study and Work in Cannabis Use and Dependence Trajectories among Young Adult Frequent Cannabis Users. FRONT PSYCHIATRY 2013;4:85 [PubMed]
  • Mann K, Bladström A, Torup L, Gual A, van den Brink W, Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. BIOL PSYCHIAT 2013;73 (8):706-713 [PubMed]
  • Matthys F, Joostens P, van den Brink W, Sabbe B, Samenvatting richtlijn 'Herkenning en behandeling van ADHD bij (jong)volwassenen met verslaving'. NED TIJDSCHR GENEESKD 2013;157 (24):A6025 [PubMed]
  • Merkx MJM, Schippers GM, Koeter MWJ, Vuijk PJ, Poch M, Kronemeijer H, van den Brink W, Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients. ADDICT BEHAV 2013;38 (3):1691-1698 [PubMed]
  • Schmaal L. Boosting impulse control in addiction. Pharmacological neuroimaging studies. s.l.: s.n.; 2013. 259p. ISBN 9789088915437 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Veltman DJ; copromotor(s): Goudriaan AE, Dom G)
  • Schmaal L, Goudriaan AE, Joos L, Krüse AM, Dom G, van den Brink W, Veltman DJ, Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. BIOL PSYCHIAT 2013;73 (8):789-795 [PubMed]
  • Schmaal L, Joos L, Koeleman M, Veltman DJ, van den Brink W, Goudriaan AE, Effects of modafinil on neural correlates of response inhibition in alcohol-dependent patients. BIOL PSYCHIAT 2013;73 (3):211-218 [PubMed]
  • Schouw MLJ, de Ruiter MB, Kaag AM, van den Brink W, Lindauer RJL, Reneman L, Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. DRUG ALCOHOL DEPEN 2013;130 (1-3):52-60 [PubMed]
  • Sjoerds Z. Alcohol dependence across the brain; from vulnerability to compulsive drinking. s.l.: s.n.; 2013. -p. Proefschrift VU, Faculteit Geneeskunde. (Promotor(s): Veltman DJ, van den Brink W, Penninx BW; copromotor(s): )
  • Sjoerds Z, de Wit S, van den Brink W, Robbins TW, Beekman ATF, Penninx BWJH, Veltman DJ, Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients. TRANSL PSYCHIAT 2013;3:e337 [PubMed]
  • Sjoerds Z, van Tol MJ, van den Brink W, van der Wee NJA, Aleman A, Beekman ATF, Penninx BWJH, Veltman DJ, Family history of alcohol dependence modulates functional neurophysiology in mood/anxiety disorders. PSYCHOL MED 2013;43 (7):1487-1497 [PubMed]
  • Sjoerds Z, van Tol MJ, van den Brink W, van der Wee NJA, van Buchem MA, Aleman A, Penninx BWJH, Veltman DJ, Family history of alcohol dependence and gray matter abnormalities in non-alcoholic adults. WORLD J BIOL PSYCHIA 2013;14 (8):565-573 [PubMed]
  • Starcke K, van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE, Physiological and endocrine reactions to psychosocial stress in alcohol use disorders: duration of abstinence matters. ALCOHOL CLIN EXP RES 2013;37 (8):1343-1350 [PubMed]
  • Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R, Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study. ADDICTION 2013;108 (12):2091-2099 [PubMed]
  • van Amsterdam J, Nutt D, van den Brink W, Generic legislation of new psychoactive drugs. J PSYCHOPHARMACOL 2013;27 (3):317-324 [PubMed]
  • van Amsterdam J, Pennings E, Brunt T, van den Brink W, Physical harm due to chronic substance use. REGUL TOXICOL PHARM 2013;66 (1):83-87 [PubMed]
  • van Amsterdam J, van den Brink W, Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. J PSYCHOPHARMACOL 2013;27 (11):987-997 [PubMed]
  • van Amsterdam J, van den Brink W, The high harm score of alcohol. Time for drug policy to be revisited?. J PSYCHOPHARMACOL 2013;27 (3):248-255 [PubMed]
  • van de Giessen E, La Fleur SE, Eggels L, de Bruin K, van den Brink W, Booij J, High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity. INT J OBESITY 2013;37 (5):754-757 [PubMed]
  • van de Glind G. ADHD in treatment seeking patients with a substance use disorder. s.l.: s.n.; 2013. 231p. ISBN 9789088916915 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Levin FR; copromotor(s): Koeter MWJ)
  • van de Glind G, van den Brink W, Koeter MWJ, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ETH, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA, Levin FR, Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. DRUG ALCOHOL DEPEN 2013;132 (3):587-596 [PubMed]
  • van de Glind G, van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MWJ, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, Schillinger A, Kapitány-Fövény M, Verspreet S, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Allsop S, Carruthers S, Schoevers RA, van den Brink W, The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. INT J METH PSYCH RES 2013;22 (3):232-244 [PubMed]
  • van den Brink W, Aubin HJ, Bladstroem A, Torup L, Gual A, Mann K, Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies (vol 48, pg 570, 2013). ALCOHOL ALCOHOLISM 2013;48 (6):746
  • van den Brink W, Aubin HJ, Bladström A, Torup L, Gual A, Mann K, Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies. ALCOHOL ALCOHOLISM 2013;48 (5):570-578 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, Facilitators and barriers in treatment seeking for cannabis dependence. DRUG ALCOHOL DEPEN 2013;133 (2):776-780 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. DRUG ALCOHOL DEPEN 2013;133 (2):352-359 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users. INT J METH PSYCH RES 2013;22 (2):138-143 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, Validation of self-reported cannabis dose and potency: an ecological study. ADDICTION 2013;108 (10):1801-1808 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, ten Have M, Korf DJ, van den Brink W, van Laar M, Mental health differences between frequent cannabis users with and without dependence and the general population. ADDICTION 2013;108 (8):1459-1469 [PubMed]
  • van Emmerik-van Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJM, van den Brink W, Schoevers RA, Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC PSYCHIATRY 2013;13 (1):132 [PubMed]
  • van Wingen GA, van den Brink W, Veltman DJ, Schmaal L, Dom G, Booij J, Crunelle CL, Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. DRUG ALCOHOL DEPEN 2013;131 (3):198-203 [PubMed]
  • van Zaane J. Bipolar disorder and alcohol: double trouble or just co-occurrence ?. s.l.: s.n.; 2013. -p. Proefschrift Rijksuniversiteit Groningen, Faculteit Geneeskunde. (Promotor(s): Nolen WA, van den Brink W; copromotor(s): Driasma S)

2012

  • Blanken P, Hendriks VM, Koeter MWJ, van Ree JM, van den Brink W, Craving and illicit heroin use among patients in heroin-assisted treatment. DRUG ALCOHOL DEPEN 2012;120 (1-3):74-80 [PubMed]
  • Boschloo L. The co-occurrence of depression and anxieety with alcohol use disorders. s.l.: s.n.; 2012. -p. Proefschrift VU, VUmc. (Promotor(s): Penninx BWJH, van den Brink W, Beekman ATF; copromotor(s): )
  • Boschloo L, van den Brink W, Penninx BWJH, Wall MM, Hasin DS, Alcohol-use disorder severity predicts first-incidence of depressive disorders. PSYCHOL MED 2012;42 (4):695-703 [PubMed]
  • Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman ATF, Penninx BWJH, Predictors of the 2-year recurrence and persistence of alcohol dependence. ADDICTION 2012;107 (9):1590-1598 [PubMed]
  • Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman ATF, Penninx BWJH, Alcohol use disorders and the course of depressive and anxiety disorders. BRIT J PSYCHIAT 2012;200 (6):476-484 [PubMed]
  • Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman ATF, Penninx BWJH, Is alcohol consumption irrelevant to outcome in anxiety and depression? Reply. BRIT J PSYCHIAT 2012;201 (4):326-327
  • Broos N, Schmaal L, Wiskerke J, Kostelijk L, Lam T, Stoop N, Weierink L, Ham J, de Geus EJC, Schoffelmeer ANM, van den Brink W, Veltman DJ, de Vries TJ, Pattij T, Goudriaan AE, The Relationship between Impulsive Choice and Impulsive Action: A Cross-Species Translational Study. PLOS ONE 2012;7 (5):e36781 [PubMed]
  • Brunt TM. Monitoring illicit psychostimulants and related health issues. s.l.: s.n.; 2012. 223p. ISBN 9789088913556 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Niesink RJM)
  • Brunt TM, Koeter MW, Niesink RJM, van den Brink W, Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. PSYCHOPHARMACOLOGY 2012;220 (4):751-762 [PubMed]
  • Brunt TM, Niesink RJM, van den Brink W, Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands. INT J DRUG POLICY 2012;23 (2):134-140 [PubMed]
  • Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW, Approach-Bias Predicts Development of Cannabis Problem Severity in Heavy Cannabis Users: Results from a Prospective FMRI Study. PLOS ONE 2012;7 (9):e42394 [PubMed]
  • Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE, Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls. NEUROIMAGE 2012;59 (4):3845-3851 [PubMed]
  • Crunelle CL. Development of new neurobiological strategies to treat patients with cocaine dependence. s.l.: s.n.; 2012. 167p. ISBN 9789088914171 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Booij J, van den Brink W; copromotor(s): )
  • Crunelle CL, de Wit TC, de Bruin K, Ramakers RM, van der Have F, Beekman FJ, van den Brink W, Booij J, Varenicline increases in vivo striatal dopamine D-2/3 receptor binding: an ultra-high-resolution pinhole [I-123]IBZM SPECT study in rats. NUCL MED BIOL 2012;39 (5):640-644 [PubMed]
  • Crunelle CL, Veltman DJ, Booij J, Emmerik-van Oortmerssen K, den Brink W, Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. BRAIN BEHAV 2012;2 (4):499-523 [PubMed]
  • Dekker N, Koeter M, van den Brink W [Contributors: Kahn RS, Linszen DH, Vanos J, Wiersma D, Bruggeman R, Cahn W, Haan Ld, Krabbendam L, Myin-Germeys I]] , Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale. INT J METH PSYCH RES 2012;21 (4):286-300 [PubMed]
  • Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I [Contributors: Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I]] , Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. PSYCHOL MED 2012;42 (9):1903-1911 [PubMed]
  • de Ruiter MB, Oosterlaan J, Veltman DJ, van den Brink W, Goudriaan AE, Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. DRUG ALCOHOL DEPEN 2012;121 (1-2):81-89 [PubMed]
  • Dom G, van den Brink W. Stoornissen in het gebruik van middelen: farmaco-therapeutische interventies in: Dierick M, Claes S, Nayer A, Cosyns P, Constant E, Souery D, editors. Handboek Psychopharmacotherapie. Gent: Academia Press; 2012., p. 203-228
  • Dom G, van den Brink W. Troubles d 'utilisation de substances: prises en charge pharmacologigues in: Dierick M, Claes S, Nayer A, Cosyns P, Constant E, Souery D, editors. Handboek Psychopharmacotherapie. Gent: Academia Press; 2012., p. 209-232
  • Goudriaan AE, van Holst RJ, Veltman DJ, van den Brink W. Neuroscience of Pathological Gambling in: Richard D, Blaszczynski A, Nower L, editors. Handbook of Pathological Gambling. S.l.: Wiley-Blackwell; 2012., p. -
  • Ingenhoven TJM, Duivenvoorden HJ, Passchier J, van den Brink W, Treatment Duration and Premature Termination of Psychotherapy in Personality Disorders: Predictive Performance of Psychodynamic Personality Functioning. J PSYCHIATR PRACT 2012;18 (3):172-186 [PubMed]
  • Kuipers MAG, van Poppel MNM, van den Brink W, Wingen M, Kunst AE, The association between neighborhood disorder, social cohesion and hazardous alcohol use: A national multilevel study. DRUG ALCOHOL DEPEN 2012;126 (1-2):27-34 [PubMed]
  • Luigjes J, van den Brink W, Feenstra M, van den Munckhof P, Schuurman PR, Schippers R, Mazaheri A, de Vries TJ, Denys D, Deep brain stimulation in addiction: a review of potential brain targets. MOL PSYCHIATR 2012;17 (6):572-583 [PubMed]
  • Oudejans SCC, Schippers GM, Spits ME , Stollenga M, van den Brink W, Vijf jaar 'routine outcome management' in de ambulante verslavingszorg. TIJDSCHR PSYCHIATR 2012;54 (2):185-190 [PubMed]
  • Reneman L, de Win MML, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CBLM, Incidental Head and Neck Findings on MRI in Young Healthy Volunteers: Prevalence and Clinical Implications. AM J NEURORADIOL 2012;33 (10):1971-1974 [PubMed]
  • Schierenberg A, van Amsterdam J, van den Brink W, Goudriaan AE, Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. CURR DRUG ABUSE REV 2012;5 (4):320-331 [PubMed]
  • Schippers G, Oudejans S, van den Brink W. ROM in de verslavingszorg in: Mulder N, editor. ROM: handreiking voor de psychiater. Den Haag: NVvP; 2012., p. 77-86
  • Schmaal L, Goudriaan AE, Meer J, Brink W, Veltman DJ, The association between cingulate cortex glutamate concentration and delay discounting is mediated by resting state functional connectivity. BRAIN BEHAV 2012;2 (5):553-562 [PubMed]
  • Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE, N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study. NEUROPSYCHOPHARMACOL 2012;37 (9):2143-2152 [PubMed]
  • Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R, The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2. DRUG ALCOHOL DEPEN 2012;123 (1-3):115-121 [PubMed]
  • Valencia-Alfonso CE, Luigjes J, Smolders R, Cohen MX, Levar N, Mazaheri A, van den Munckhof P, Schuurman PR, van den Brink W, Denys D, Effective Deep Brain Stimulation in Heroin Addiction: A Case Report with Complementary Intracranial Electroencephalogram. BIOL PSYCHIAT 2012;71 (8):E35-E37 [PubMed]
  • van Amsterdam JGC, Brunt TM, McMaster MTB, Niesink R, van Noorden MS, van den Brink W, Cognitieve schade door intensief gebruik en overdoses van GHB. TIJDSCHR PSYCHIATR 2012;54 (12):1001-1010 [PubMed]
  • van Amsterdam JGC, Brunt T, Niesink R, Opperhuizen A, van den Brink W. Mogelijke neurotoxische effecten van GHB. Bilthoven: RIVM; 2012. -p.
  • van Amsterdam JGC, van Laar M, Brunt TM, van den Brink W, Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. REGUL TOXICOL PHARM 2012;63 (1):55-63 [PubMed]
  • van de Giessen E. Neurobiological aspects of obesity: dopamine, srotonin, and imaging. s.l.: s.n.; 2012. 302p. ISBN 9789461821706 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Booij J, van den Brink W; copromotor(s): Baas F, La Fleur SE)
  • van de Giessen E, de Bruin K, la Fleur SE, van den Brink W, Booij J, Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats. EUR NEUROPSYCHOPHARM 2012;22 (4):290-299 [PubMed]
  • van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J, Free-Choice and No-Choice High-Fat Diets Affect Striatal Dopamine D-2/3 Receptor Availability, Caloric Intake, and Adiposity. OBESITY 2012;20 (8):1738-1740 [PubMed]
  • van de Giessen E, Nimgaonkar VL, Watson AM, Kodavali C, Baas F, Tanck MWT, de Win MML, van den Brink W, Booij J, Association Tests of Striatal DAT Availability and SNPs That Impact a Novel Splice Variant in the DAT Gene. J NUCL MED 2012;53 (5):839 [PubMed]
  • van de Mheen D, van den Brink W. Uitvoering en organisatie van de publieke gezondheidszorg; thema E: verslavingszorg in: Mackenbach JP, Stronks K, editors. Volksgezondheid en gezondheidszorg [6e geheel herziene druk]. Amsterdam: Reed Business; 2012., p. 288-294
  • van den Brink W, Evidence-based pharmacological treatment of substance use disorders and pathological gambling. CURR DRUG ABUSE REV 2012;5 (1):3-31 [PubMed]
  • van den Brink W. Evidence-based pharmacotherapy of illicit substance use disorders in: Stein DJ, Lerer B, Stahl SM, editors. Essential evidence-based psychopharmacology (second edition). Cambridge: Cambridge University Press; 2012., p. 241-261
  • van den Brink W, Pensioentoewijzing en de rol van motiverende gespreksvoering, stagering en profilering. VERSLAVING 2012;8:7-12
  • van den Brink W. Stoornissen in het gebruik van alcohol in: Franken I, Muris P, Denys D, editors. Basisboek psychopathologie. Utrecht: De Tijdstroom; 2012., p. 265-282
  • van den Brink W. Stoornissen in het gebruik van middelen in: Hengeveld MW, van Balkom AJLM, van Heeringen C, Sabbe BGC, editors. Leerboek Psychiatrie (2e geheel herz. druk). Utrecht: De Tijdstroom; 2012., p. 457-479
  • van den Brink W. Stoornissen in het gebruik van middelen in: Pepplinkhuizen L, Verhoeven WMA, Sitsen JMA, editors. Het psychiatrisch formularium: een praktische leidraad. Houten: Bohn Stafleu van Loghum; 2012., p. 75-90
  • van den Brink W, Schippers GM, Stagering en profilering bij verslaving. TIJDSCHR PSYCHIATR 2012;54 (11):941-948 [PubMed]
  • van Dijk D, Koeter MWJ, Hijman R, Kahn RS, van den Brink W, Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study. SCHIZOPHR RES 2012;137 (1-3):50-57 [PubMed]
  • van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA, Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. DRUG ALCOHOL DEPEN 2012;122 (1-2):11-19 [PubMed]
  • van Holst RJ, de Ruiter MB, van den Brink W, Veltman DJ, Goudriaan AE, A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. DRUG ALCOHOL DEPEN 2012;124 (1-2):142-148 [PubMed]
  • van Holst RJ, van der Meer JN, McLaren DG, van den Brink W, Veltman DJ, Goudriaan AE, Interactions between Affective and Cognitive Processing Systems in Problematic Gamblers: A Functional Connectivity Study. PLOS ONE 2012;7 (11):e49923 [PubMed]
  • van Holst RJ, van Holstein M, van den Brink W, Veltman DJ, Goudriaan AE, Response Inhibition during Cue Reactivity in Problem Gamblers: An fMRI Study. PLOS ONE 2012;7 (3):e30909 [PubMed]
  • van Holst RJ, Veltman DJ, Büchel C, van den Brink W, Goudriaan AE, Distorted Expectancy Coding in Problem Gambling: Is the Addictive in the Anticipation?. BIOL PSYCHIAT 2012;71 (8):741-748 [PubMed]
  • van Holst RJ, Veltman DJ, van den Brink W, Goudriaan AE, Right on Cue? Striatal Reactivity in Problem Gamblers. BIOL PSYCHIAT 2012;72 (10):E23-E24 [PubMed]
  • van Zaane J, van den Berg B, Draisma S, Nolen WA, van den Brink W, Screening for bipolar disorders in patients with alcohol or substance use disorders: Performance of the Mood Disorder Questionnaire. DRUG ALCOHOL DEPEN 2012;124 (3):235-241 [PubMed]
  • Veldhuis J, Dieleman JP, Wohlfarth T, Storosum JG, van den Brink W, Sturkenboom MCJM, Denys D, Incidence and prevalence of "diagnosed OCD" in a primary care, treatment seeking, population. INT J PSYCHIAT CLIN 2012;16 (2):85-92 [PubMed]

2011

  • Blanken P. Heroin-assisted treatment. From efficacy to effectiveness and long-term outcome. s.l.: s.n.; 2011. 208p. ISBN 9789461690142 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, van Ree JM; copromotor(s): Hendriks VM)
  • Blom RM, Koeter M, van den Brink W, de Graaf R, ten Have M, Denys D, Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population. ADDICTION 2011;106 (12):2178-2185 [PubMed]
  • Boschloo L, Vogelzangs N, Licht CMM, Vreeburg SA, Smit JH, van den Brink W, Veltman DJ, de Geus EJC, Beekman ATF, Penninx BWJH, Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. DRUG ALCOHOL DEPEN 2011;116 (1-3):170-176 [PubMed]
  • Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman ATF, Penninx BWJH, Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J AFFECT DISORDERS 2011;131 (1-3):233-242 [PubMed]
  • Brunt TM, Poortman A, Niesink RJM, van den Brink W, Instability of the ecstasy market and a new kid on the block: mephedrone. J PSYCHOPHARMACOL 2011;25 (11):1543-1547 [PubMed]
  • Burke SM, van de Giessen E, de Win M, Schilt T, van Herk M, van den Brink W, Booij J, Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects. PSYCHOL MED 2011;41 (2):419-429 [PubMed]
  • Buster MCA, van den Brink W, van Brussel GHA, van Ree JM, Influence of treatment with inhalable heroin on pulmonary function. EUR ADDICT RES 2011;17 (3):136-138 [PubMed]
  • Crunelle CL , Schulz S, de Bruin K, Miller ML , van den Brink W, Booij J, Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. EUR NEUROPSYCHOPHARM 2011;21 (2):205-210 [PubMed]
  • El Marroun H, Hudziak JJ, Tiemeier H, Creemers H, Steegers EAP, Jaddoe VWV, Hofman A, Verhulst FC, van den Brink W, Huizink AC, Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. DRUG ALCOHOL DEPEN 2011;118 (2-3):470-474 [PubMed]
  • El Marroun H, Tiemeier H, Jaddoe VWV, Hofman A, Verhulst FC, van den Brink W, Huizink AC, Agreement between Maternal Cannabis Use during Pregnancy according to Self-Report and Urinalysis in a Population-Based Cohort: The Generation R Study. EUR ADDICT RES 2011;17 (1):37-43 [PubMed]
  • Ingenhoven TJM, van den Brink W, Passchier J, Duivenvoorden HJ, Treatment-Disrupting Behaviors during Psychotherapy of Patients with Personality Disorders: The Predictive Power of Psychodynamic Personality Diagnosis. J PSYCHIATR PRACT 2011;17 (1):21-34 [PubMed]
  • Kiefer F, van den Brink W, European Addiction Research: A New Editor, a New Advisory Board and Intriguing Perspectives. EUR ADDICT RES 2011;17 (2):I-II [PubMed]
  • Luigjes J, Mantione M, van den Brink W, Schuurman PR, van den Munckhof P, Denys D, Deep brain stimulation increases impulsivity in two patients with obsessive-compulsive disorder. INT CLIN PSYCHOPHARM 2011;26 (6):338-340 [PubMed]
  • Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, Franken IHA, Neurobiological substrate of smoking-related attentional bias. NEUROIMAGE 2011;54 (3):2374-2381 [PubMed]
  • Merkx MJM, Schippers GM, Koeter MWJ, Vuijk PJ, Oudejans SCC, Stam RK, van den Brink W, Guidelines for allocating outpatient alcohol abusers to levels of care: Predictive validity. ADDICT BEHAV 2011;36 (6):570-575 [PubMed]
  • Nuijten M, Blanken P, van den Brink W, Hendriks V, Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the Netherlands. BMC PSYCHIATRY 2011;11 (1):135 [PubMed]
  • Oudejans SCC, Schippers GM, Schramade MH, Koeter MWJ, van den Brink W, Measuring the learning capacity of organisations: development and factor analysis of the Questionnaire for Learning Organizations. BMJ QUAL SAF 2011;20 (4):307-313 [PubMed]
  • Schmaal L, Berk L, Hulstijn KP, Cousijn J, Wiers RW, van den Brink W, Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. EUR ADDICT RES 2011;17 (4):211-216 [PubMed]
  • Sekar V, Tomaka F, Lefebvre E, de Pauw M, Vangeneugden T, van den Brink W, Hoetelmans R, Pharmacokinetic Interactions Between Darunavir/Ritonavir and Opioid Maintenance Therapy Using Methadone or Buprenorphine/Naloxone. J CLIN PHARMACOL 2011;51 (2):271-278 [PubMed]
  • Soyka M, Kranzler HR, van den Brink W, Krystal J, Moeller HJ, Kasper S, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence (vol 12, pg 160, 2011). WORLD J BIOL PSYCHIA 2011;12 (5):397
  • Soyka M, Kranzler HR, van den Brink W, Krystal J, Möller HJ, Kasper S, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. WORLD J BIOL PSYCHIA 2011;12 (3):160-187 [PubMed]
  • van Amsterdam J, Opperhuizen A, van den Brink W, Harm potential of magic mushroom use: A review. REGUL TOXICOL PHARM 2011;59 (3):423-429 [PubMed]
  • van de Giessen E, Groot PFC, Booij J, van den Brink W, Veltman DJ, Nederveen AJ, Functional MR imaging on an open 1T MR imaging system: exploiting the advantages of an open MR imaging system for functional MR imaging. AM J NEURORADIOL 2011;32 (5):903-907 [PubMed]
  • van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M, The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. INT J METH PSYCH RES 2011;20 (3):169-181 [PubMed]
  • van Holst RJ. Imagingstudies in pathological gambling: similarities and differences with alcohol dependence. s.l.: s.n.; 2011. 238p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Veltman DJ; copromotor(s): Goudriaan AE)
  • Zandi T, Havenaar JM, Kahn RS, van den Brink W, Incidence of schizophrenia among Moroccan immigrants to the Netherlands. Response to letter written by Selten et al. SCHIZOPHR RES 2011;128 (1-3):173-174 [PubMed]
  • Zandi T, Havenaar JM, Laan W, Kahn RS, van den Brink W, Predictive validity of a culturally informed diagnosis of schizophrenia: a 30 month follow-up study with first episode psychosis. SCHIZOPHR RES 2011;133 (1-3):29-35 [PubMed]

2010

  • Blanken P, Hendriks VM, van Ree JM, van den Brink W, Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. ADDICTION 2010;105 (2):300-308 [PubMed]
  • Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, Wakelin JS, Barendrecht C, Beijnen JH, van Ree JM, Heroin-assisted treatment in the Netherlands: History, findings, and international context. EUR NEUROPSYCHOPHARM 2010;20 (Suppl. 2):S105-S158 [PubMed]
  • Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman ATF, Penninx BWJH, The performance of the Alcohol Use Disorder Identification Test (AUDIT) in detecting alcohol abuse and dependence in a population of depressed or anxious persons. J AFFECT DISORDERS 2010;126 (3):441-446 [PubMed]
  • Brunt TM, van Laar M, Niesink RJM, van den Brink W, The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes. DRUG ALCOHOL DEPEN 2010;111 (1-2):21-29 [PubMed]
  • Colins O, Vermeiren R, Vreugdenhil C, van den Brink W, Doreleijers T, Broekaert E, Psychiatric Disorders in Detained Male Adolescents: A Systematic Literature Review. CAN J PSYCHIAT 2010;55 (4):255-263 [PubMed]
  • Crunelle CL, Miller ML, Booij J, van den Brink W, The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review. EUR NEUROPSYCHOPHARM 2010;20 (2):69-79 [PubMed]
  • de Wildt WAJM. Alcohol dependence: treatment effectiveness and the concept of graving. s.l.: s.n.; 2010. 145p. ISBN 9789088911491 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Schippers GM, van den Brink W; copromotor(s): Lehert P)
  • El Marroun H. Prenatal cannabis exposure and infant development: "A tolerated matter.". Rotterdam: s.n.; 2010. 201p. ISBN 978-90-8559-928-9 Proefschrift Erasmus Universiteit Rotterdam, Child and Adolescent Psychiatry. (Promotor(s): Verhulst FC, van den Brink W, Huizink AC; copromotor(s): )
  • El Marroun H, Tiemeier H, Steegers EAP, Roos-Hesselink JW, Jaddoe VWV, Hofman A, Verhulst FC, van den Brink W, Huizink AC, A prospective study on intrauterine cannabis exposure and fetal blood flow. EARLY HUM DEV 2010;86 (4):231-236 [PubMed]
  • Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ, Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. ADDICT BIOL 2010;15 (4):491-503 [PubMed]
  • Koeter MWJ, van den Brink W, Lehert P, Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence. J SUBST ABUSE TREAT 2010;39 (3):218-226 [PubMed]
  • Schilt T, Koeter MWJ, Smal JP, Gouwetor MN, van den Brink W, Schmand B, Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. PSYCHOPHARMACOLOGY 2010;207 (4):583-591 [PubMed]
  • Schippers GM, Broekman TG, Buchholz A, Koeter MWJ, van den Brink W, Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. ADDICTION 2010;105 (5):862-871 [PubMed]
  • Sizoo BB. Developmental disorders and sunstance use disorders: a phenotypical, endophenotypical and genetic exploration. Nijmegen: s.n.; 2010. 152p. ISBN 978-90-9025003-8 Proefschrift UMCst Radboud Katholieke Universiteit Nijmegen, .. (Promotor(s): van der Gaag RJ, van den Brink W; copromotor(s): Koeter MWJ, Gorissen van Eenige M)
  • Sizoo B, van den Brink W, Franke B, Vasquez AA, van Wijngaarden-Cremers P, van der Gaag RJ, Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders?. WORLD J BIOL PSYCHIA 2010;11 (5):699-708 [PubMed]
  • Sizoo B, van den Brink W, Koeter M, Gorissen van Eenige M, van Wijngaarden-Cremers P, van der Gaag RJ, Treatment seeking adults with autism or ADHD and co-morbid Substance Use Disorder: Prevalence, risk factors and functional disability. DRUG ALCOHOL DEPEN 2010;107 (1):44-50 [PubMed]
  • van Amsterdam J, Opperhuizen A, Koeter M, van den Brink W, Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population. EUR ADDICT RES 2010;16 (4):202-207 [PubMed]
  • van Amsterdam J, van den Brink W, Ranking of drugs: a more balanced risk-assessment. LANCET 2010;376 (9752):1524-1525 [PubMed]
  • van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE, Brain Imaging Studies in Pathological Gambling. CURR PSYCHIAT REP 2010;12 (5):418-425 [PubMed]
  • van Holst RJ, van den Brink W, Veltman DJ, Goudriaan AE, Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. NEUROSCI BIOBEHAV R 2010;34 (1):87-107 [PubMed]
  • van Nimwegen-Campailla L, van Beveren N, Laan W, van den Brink W, Linszen D, de Haan L, Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis. PHARMACOPSYCHIATRY 2010;43 (7):281-282 [PubMed]
  • van Zaane J, van den Brink W, Draisma S, Smit JH, Nolen WA, The Effect of Moderate and Excessive Alcohol Use on the Course and Outcome of Patients With Bipolar Disorders: A Prospective Cohort Study. J CLIN PSYCHIAT 2010;71 (7):885-893 [PubMed]
  • Zandi T, Havenaar JM, Smits M, Limburg-Okken AG, van Es H, Cahn W, Algra A, Kahn RS, van den Brink W, First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: Influence of diagnostic bias. SCHIZOPHR RES 2010;119 (1-3):27-33 [PubMed]

2009

  • Braakman MH, Kortmann FAM, van den Brink W, Validity of 'post-traumatic stress disorder with secondary psychotic features': a review of the evidence. ACTA PSYCHIAT SCAND 2009;119 (1):15-24 [PubMed]
  • Couwenbergh C. Substance abuse and its co-occurrence with other mental health problems in adolescents. Nijmegen: s.n.; 2009. 136p. ISBN 978-90-9023991-0 Proefschrift Radboud Universiteit Nijmegen, -. (Promotor(s): van der Gaag RJ, van den Brink W; copromotor(s): Koeter MWJ)
  • Couwenbergh C, van der Gaag RJ, Koeter M, de Ruiter C, van den Brink W, Screening for Substance Abuse Among Adolescents Validity of the CAGE-AID in Youth Mental Health Care. SUBST USE MISUSE 2009;44 (6):823-834 [PubMed]
  • Crunelle CL, Miller ML, de Bruin K, van den Brink W, Booij J, Varenicline increases striatal dopamine D(2/3) receptor binding in rats. ADDICT BIOL 2009;14 (4):500-502 [PubMed]
  • de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, van den Brink W, Response Perseveration and Ventral Prefrontal Sensitivity to Reward and Punishment in Male Problem Gamblers and Smokers. NEUROPSYCHOPHARMACOL 2009;34 (4):1027-1038 [PubMed]
  • Dols A, van den Brink W, Eikelenboom P, Vaccinaties in de psychiatrie. TIJDSCHR PSYCHIATR 2009;51 (10):751-759 [PubMed]
  • El Marroun H, Tiemeier H, Steegers EAP, Jaddoe VWV, Hofman A, Verhulst FC, van den Brink W, Huizink AC, Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J AM ACAD CHILD PSY 2009;48 (12):1173-1181 [PubMed]
  • Franken IHA, van den Brink W, editors, Handboek verslaving. Utrecht: De Tijdstroom; 2009. 538p. ISBN 9789058981400
  • Ingenhoven TJM. The role of psychodynamic assessment in diagnosis and treatment of personality disorders. Reliability and validity of the developmental profile. Rotterdam: s.n.; 2009. 214p. ISBN 978-90-9024532-4 Proefschrift Erasmus Universiteit Rotterdam, -. (Promotor(s): Passchier J, van den Brink W; copromotor(s): Duivenvoorden HJ)
  • Ingenhoven TJM, Duivenvoorden HJ, Brogtrop J, Lindenborn A, van den Brink W, Passchier J, Brief Communications: Interrater Reliability for Kernberg's Structural Interview for Assessing Personality Organization. J PERS DISORD 2009;23 (5):528-534 [PubMed]
  • Nabitz U, Jansen P, van der Voet S, van den Brink W, Psychosocial work conditions and work stress in an innovating addiction treatment centre. Consequences for the EFQM Excellence Model. TOTAL QUAL MANAG BUS 2009;20 (3):267-281
  • Ooteman W, Naassila M, Koeter MWJ, Verheul R, Schippers GM, Houchi H, Daoust M, van den Brink W, Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. ADDICT BIOL 2009;14 (3):328-337 [PubMed]
  • Oudejans SCC. Routine outcome monitoring and learning organizations in substance abuse treatment. s.l.: s.n.; 2009. 151p. ISBN 9789090241326 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Schippers GM, van den Brink W; copromotor(s): Koeter MWJ)
  • Oudejans SCC, Schippers GM, Merkx MJM, Schramade MH, Koeter MWJ, van den Brink W, Feasibility and validity of low-budget telephonic follow-up interviews in routine outcome monitoring of substance abuse treatment. ADDICTION 2009;104 (7):1138-1146 [PubMed]
  • Schilt T. Thinking of ectacy. Neuropsychological aspects of ectasy use. s.l.: s.n.; 2009. 125p. ISBN 9789088911071 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Schmand B; copromotor(s): Koeter MWJ, de Win MML)
  • Schilt T, Goudriaan AE, Koeter MW, van den Brink W, Schmand B, Decision making as a predictor of first ecstasy use: a prospective study. PSYCHOPHARMACOLOGY 2009;203 (3):519-527 [PubMed]
  • Schilt T, Koeter MWJ, de Win MML, Zinkstok JR, van Amelsvoort TA, Schmand B, van den Brink W, The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene. EUR NEUROPSYCHOPHARM 2009;19 (2):116-124 [PubMed]
  • Sizoo BB, van den Brink W, Gorissen-van Eenige M, Koeter MW, van Wijngaarden-Cremers PJM, van der Gaag RJ, Using the Autism-Spectrum Quotient to Discriminate Autism Spectrum Disorder from ADHD in Adult Patients With and Without Comorbid Substance Use Disorder. J AUTISM DEV DISORD 2009;39 (9):1291-1297 [PubMed]
  • Sizoo B, van den Brink W, van Eenige MG, van der Gaag RJ, Personality Characteristics of Adults With Autism Spectrum Disorders or Attention Deficit Hyperactivity Disorder With and Without Substance Use Disorders. J NERV MENT DIS 2009;197 (6):450-454 [PubMed]
  • van Amsterdam JGC, Opperhuizen A, Koeter MWJ, Aerts LAGJM, van den Brink W. Ranking van drugs. Een vergelijking van de schadelijkheid van drugs.. Bilthoven: RIVM; 2009. 98p.
  • van de Donk WBHJ, Boekhout P, van den Brink W, Fijnaut C, Horstink-von Meyenfeldt SJE, van de Mheen D, Rigter H, van Vliet-Kuiper A, Berghuis AC, de Zwart WM, Verslavingsproblematiek jongeren verknoopt met ander deviant gedrag. Aanknopingspunten voor preventie. VERSLAVING 2009;5:19-28
  • van de Giessen EM, de Win MML, Tanck MWT, van den Brink W, Baas F, Booij J, Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3. J NUCL MED 2009;50 (1):45-52 [PubMed]
  • van den Brink W. Farmacotherapie in: Buisman WR, Casselman J, Majoor LBJ, Schippers GM, Silvis J, Walburg JA, editors. Handboek verslaving. Houten: Bohn Stafleu Van Loghum; 2003., p. 359-385
  • van den Brink W. Geschiedenis en classificatie in: Buisman WR, Casselman J, Majoor LBJ, Schippers GM, Silvis J, Walburg JA, editors. Handboek verslaving. Houten: Bohn Stafleu Van Loghum; 2003., p. 13-25
  • van den Brink W, Heroin assisted treatment. BMJ-BRIT MED J 2009;339:b4545 [PubMed]
  • van den Brink W. Hoe schadelijk is cannabis? in: de Donder E, editor. Illegale drugs: cijfers in persepctief (1997-2007). Antwerpen: Garant; 2009., p. 319-326
  • van den Brink W, Verslaving een chronisch recidiverende hersenziekte. TIJDSCHR BEDRIJFS VERZEKERINGSGENEESKD 2009;17:155-160
  • van den Brink W, Dom G. Stoornissen in het gebruik van middelen in: Hengeveld MW, van Balkom AJLM, editors. Leerboek psychiatrie (2e dr.). Utrecht: De Tijdstroom; 2009., p. 457-479
  • Vanderschuren LJMJ, Matthys W, van den Brink W, Stoornissen van de impulsregulatie. Pathofysiologie en behandeling. NED TIJDSCHR GENEESKD 2009;153 (6):240-243 [PubMed]
  • van de Wetering BJM, Franken IHA, van den Brink W. Neurobiologie in: Buisman WR, Casselman J, Majoor LBJ, Schippers GM, Silvis J, Walburg JA, editors. Handboek verslaving. Houten: Bohn Stafleu Van Loghum; 2003., p. 153-163
  • Wohlfarth T, Linszen D, van den Brink W, Blinding in clozapine trials: a problem and a potential solution. INT J METH PSYCH RES 2009;18 (3):185-188 [PubMed]
  • Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IHA, Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. DRUG ALCOHOL DEPEN 2009;99 (1-3):183-192 [PubMed]

2008

  • Braakman MH, Kortmann FAM, van den Brink W, Verkes RJ, Posttraumatic stress disorder with secondary psychotic features: neurobiological findings. PROG BRAIN RES 2008;167:299-302 [PubMed]
  • de Win MML, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W, Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. BRAIN 2008;131 (Part 11):2936-2945 [PubMed]
  • de Win MML, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, den Heeten GJ, van den Brink W, Neurotoxic effects of ecstasy on the thalamus. BRIT J PSYCHIAT 2008;193 (4):289-296 [PubMed]
  • Duits N, Doreleijers TAH, van den Brink W, Assessment of violence risk in youth for juvenile court: relevant factors for clinical judgment. INT J LAW PSYCHIAT 2008;31 (3):236-240 [PubMed]
  • El Marroun H, Tiemeier H, Jaddoe VWV, Hofman A, Mackenbach JP, Steegers EAP, Verhulst FC, van den Brink W, Huizink AC, Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study. DRUG ALCOHOL DEPEN 2008;98 (3):218-226 [PubMed]
  • Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W, The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. PSYCHOL MED 2008;38 (1):41-50 [PubMed]
  • Jager G, de Win MML, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF, Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. NEUROPSYCHOPHARMACOL 2008;33 (2):247-258 [PubMed]
  • Nabitz U, Witteveen E, van Santen G, van den Brink W, Die niederländische Studie zur heroingestützten Behandlung und Implementierung strukturierter Behandlungverläufe von substituierten Patienten. ABHÄNGIGKEITEN 2008;3:66-82
  • Schadé A, Marquenie LA, van Balkom AJLM, Koeter MWJ, van den Brink W, van Dyck R, Effectiviteit van een toegevoegde behandeling voor angstklachten bij alcoholafhankelijke patiënten met een fobische stoornis. TIJDSCHR PSYCHIATR 2008;50 (3):137-148 [PubMed]
  • Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B, No evidence of decrease in cognitive function in users of low-dose ecstasy - Reply. ARCH GEN PSYCHIAT 2008;65 (2):236-237
  • Schilt T, de Win MML, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W, Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. PSYCHOL MED 2008;38 (9):1309-1317 [PubMed]
  • Schippers GM, van den Brink W. Stoornissen in en door het gebruik van psychoactieve stoffen in: Vandereycken W, Hoogduin CAL, Emmelkamp PMG, editors. Handboek psychopathologie. Deel 1. Basisbegrippen. vierde druk. Houten: Van Loghum; 2008., p. 125-153
  • Schöller-Gyüre M, van den Brink W, Kakuda TN, Woodfall B, de Smedt G, Vanaken H, Stevens T, Peeters M, Vandermeulen K, Hoetelmans RMW, Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers. J CLIN PHARMACOL 2008;48 (3):322-329 [PubMed]
  • van den Brink W, editor, Drugs en alcohol, gebruik, misbruik en verslaving. Houten: Bohn Stafleu van Loghum; 2008. -p.
  • van den Brink W, Forum: Decriminalization of cannabis. CURR OPIN PSYCHIATR 2008;21 (2):122-126 [PubMed]
  • van den Brink W, Schippers GM, Verslaving en verslavingszorg. TIJDSCHR PSYCHIATR 2008;50 (13):91-97 [PubMed]
  • van Nimwegen L, de Haan L, van Beveren N, Laan W, van den Brink W, Linszen D, Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J CLIN PSYCHOPHARM 2008;28 (2):214-218 [PubMed]
  • van Nimwegen LJ, de Haan L, van Beveren NJ, van der Helm M, van den Brink W, Linszen D, Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. CAN J PSYCHIAT 2008;53 (6):400-405 [PubMed]
  • van Nimwegen LJM. Well-being and co-morbidity in recent onset schizophrenia. s.l.: s.n.; 2008. 167p. ISBN 9789085594178 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Linszen DH, Hengeveld MW; copromotor(s): de Haan L, van den Brink W)
  • Vervaeke HKE, Benschop A, van den Brink W, Korf DJ, Predicting ecstasy use among young people at risk: a prospective study of initially ecstasy-naive subjects. J DRUG EDUC 2008;38 (2):131-146 [PubMed]
  • Wohlfarth T, van den Brink W, Storosum J, Misinterpretation in Krsch et al's article. Response to Kirsch et al. Initial severity and antidepressant benefits: a meta-analysisof data submitted to the FDA. PLOS MED 2008;5:-
  • Zandi T, Havenaar JM, Limburg-Okken AG, van Es H, Sidali S, Kadri N, van den Brink W, Kahn RS, The need for culture sensitive diagnostic procedures. SOC PSYCH PSYCH EPID 2008;43 (3):244-250 [PubMed]
  • Zijlstra F, Booij J, van den Brink W, Franken IHA, Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. EUR NEUROPSYCHOPHARM 2008;18 (4):262-270 [PubMed]

2007

  • Demetrovics Z, Barth A, Bognar G, Kun B, van den Brink W, Knowledge of and attitudes about drug addicts and their treatment among psychiatrists in Hungary (in Polish). ALKOHOLIZM I NARKOMANIA 2007;20:303-312
  • de Win MML. Neurotoxity of ecstacy: causality, course, and clinical relevance. s.l.: s.n.; 2007. 335p. ISBN 9789090214924 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, den Heeten GJ; copromotor(s): Booij J, Reneman L)
  • de Win MML, Reneman L, Jager G, Vlieger EJP, Olabarriaga SD, Lavini C, Bisschops I, Majoie CBLM, Booij J, den Heeten GJ, van den Brink W, A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. NEUROPSYCHOPHARMACOL 2007;32 (2):458-470 [PubMed]
  • Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, Strang J, van den Brink W, Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J URBAN HEALTH 2007;84 (4):552-562 [PubMed]
  • Helzer JE, Guth SE, van den Brink W, The SDSS Scale - A reply to Gonzalez-Saiz. ADDICTION 2007;102 (5):828-829
  • Helzer JE, van den Brink W, Guth SE. Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? in: Saunders JB, Schucjit MA, Sirovatka PJ, Regier DA, editors. Diagnostics issues in substance use disorders: refining the research agenda for DSM-V. Arlington VA: American Psychiatric Association; 2007., p. 21-30
  • Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF, Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. PSYCHOPHARMACOLOGY 2007;193 (3):403-414 [PubMed]
  • Jager G, van Hell HH, de Win MML, Kahn RS, van den Brink W, van Ree JM, Ramsey NF, Effects of frequent cannabis use on hippocampal activity during an associative memory task. EUR NEUROPSYCHOPHARM 2007;17 (4):289-297 [PubMed]
  • Klous MG, Nuijen B, van den Brink W, van Ree JM, Beijnen JH, Farmaceutische ontwikkeling van toedieningsvormen van diacetylmorfine voor heroineverslaafden. PHARM WEEKBL 2007;142:98-104
  • Marissen MAE, Franken IHA, Blanken P, van den Brink W, Hendriks VM, Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial. PSYCHOTHER PSYCHOSOM 2007;76 (2):97-105 [PubMed]
  • Marquenie LA, Schade A, van Balkom AJLM, Comijs HC, de Graaf R, Vollebergh W, van Dyck R, van den Brink W, Origin of the comorbidity of anxiety disorders and alcohol dependence: findings of a general population study. EUR ADDICT RES 2007;13 (1):39-49 [PubMed]
  • Merkx MJM, Schippers GM, Koeter MJW, Vuijk PJ, Oudejans S, de Vries CCQ, van den Brink W, Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres. ADDICTION 2007;102 (3):466-474 [PubMed]
  • Ooteman W, Koeter MWJ, Verheul R, Schippers GM, van den Brink W, The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. EUR NEUROPSYCHOPHARM 2007;17 (8):558-566 [PubMed]
  • Popma A, Vermeiren R, Geluk CAML, Rinne T, van den Brink W, Knol DL, Jansen LMC, van Engeland H, Doreleijers TAH, Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents. BIOL PSYCHIAT 2007;61 (3):405-411 [PubMed]
  • Rehm J, van den Brink W, 15 Jahre Forschung zu ärtzlich verschriebenem Heroin: Wie passen die Ergebnisse des deutschen Heroinsversuchs in das Puzzle der schweizerischen und niederländischen Ergebnisse?. SUCHT 2007;53:262-264
  • Repko M, van den Brink W, Huyser J, Kunnen patiënten met een depressieve stoornis stoppen met roken?. TIJDSCHR PSYCHIATR 2007;49 (10):753-762 [PubMed]
  • Roozen HG, de Waart R, van den Brink W, Efficacy and tolerability of naltrexone in the treatment of alcohol dependence: oral versus injectable delivery. EUR ADDICT RES 2007;13 (4):201-206 [PubMed]
  • Schade A, Marquenie LA, van Balkom AJLM, Koeter MWJ, de Beurs E, van Dyck R, van den Brink W, Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence. EUR ADDICT RES 2007;13 (2):109-115 [PubMed]
  • Schadé A, Marquenie L, van den Brink W. Alcohol en angst in: van Balkom T, Beekman A, Hoogendijk W, editors. Verwetenschappelijking van de psychiatrie. Liber amicorum voor Richard van Dyck. s.l.: s.n.; 2007., p. -
  • Schilt T, de Win MML, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B, Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. ARCH GEN PSYCHIAT 2007;64 (6):728-736 [PubMed]
  • Storosum JG, Wohlfarth T, Schene A, Elferink A, van Zwieten BJ, van den Brink W, Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. BIPOLAR DISORD 2007;9 (8):793-798 [PubMed]
  • van den Brink W. Verslaving: visies en persoonlijke ervaring in: Swinkels JA, Boer F, editors. N=1: over psychiatrie met een menselijke maat. Amsterdam: Benecke; 2007., p. 47-54
  • van den Brink W, DeFuentes-Merillas L, Goudriaan A, Koeter M. Pathologisch gokken in: Denys D, de Geus F, editors. Handboek obsessieve-compulsieve stoornissen. Utrecht: De Tijdstroom; 2007., p. 289-305
  • van der Zanden BP, Dijkgraaf MGW, Blanken P, van Ree JM, van den Brink W, Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. DRUG ALCOHOL DEPEN 2007;86 (1):84-90 [PubMed]
  • van Nimwegen L, de Haan L, van Beveren N, van den Brink W, Linszen D, Adolescentie, schizofrenie en drugs: interacterende kwetsbaarheid. Een hypothese. TIJDSCHR PSYCHIATR 2007;49 (3):169-178 [PubMed]
  • Ventevogel P, de Vries G, Scholte WF, Shinwari NR, Faiz H, Nassery R, van den Brink W, Olff M, Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. SOC PSYCH PSYCH EPID 2007;42 (4):328-335 [PubMed]
  • Vervaeke HKE, Korf DJ, Benschop A, van den Brink W, How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context. ADDICT BEHAV 2007;32 (8):1705-1713 [PubMed]
  • Wohlfarth T, Boer F, van den Brink W, Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents. AM J PSYCHIAT 2007;164 (12):1908; author reply 1908-1908; author reply 1910 [PubMed]

2006

  • Aarsse R, van den Brink W, Koeter MWJ, Een goede werkrelatie en een tevreden cliënt: een goed behandelresultaat?. TIJDSCHR PSYCHOTHER 2006;32:178-192
  • Couwenbergh C, van den Brink W, Zwart K, Vreugdenhil C, van Wijngaarden-Cremers P, van der Gaag RJ, Comorbid psychopathology in adolescents and young adults treated for substance use disorders: a review. EUR CHILD ADOLES PSY 2006;15 (6):319-328 [PubMed]
  • de Bruijn C, van den Brink W, de Graaf R, Alcoholisme: een chronische recidiverende ziekte? Het beloop van alcoholgerelateerde stoornissen in de algemene bevolking. VERSLAVING 2006;2 (1):50-60
  • de Bruijn C, van den Brink W, de Graaf R, Vollebergh WAM, The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model. ADDICTION 2006;101 (3):385-392 [PubMed]
  • de Win MML, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W, Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J PSYCHOPHARMACOL 2006;20 (2):226-235 [PubMed]
  • Dom G, de Wilde B, Hulstijn W, van den Brink W, Sabbe B, Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder. ALCOHOL ALCOHOLISM 2006;41 (4):412-420 [PubMed]
  • Dom G, de Wilde B, Hulstijn W, van den Brink W, Sabbe B, Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. ALCOHOL CLIN EXP RES 2006;30 (10):1670-1677 [PubMed]
  • Dom G, Sabbe B, Hulstijn W, van den Brink W, Neurobehavioural characteristics and relapse in addiction - Reply. BRIT J PSYCHIAT 2006;188:494
  • Duits N. Kwaliteit onderzoek pro Justitia van jongeren. S.l.: s.n.; 2006. 219p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Doreleijers TAH; copromotor(s): )
  • Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W, Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. ADDICTION 2006;101 (4):534-547 [PubMed]
  • Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W, Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. DRUG ALCOHOL DEPEN 2006;84 (3):231-239 [PubMed]
  • Haasen C, van den Brink W, Innovations in agonist maintenance treatment of opioid-dependent patients. CURR OPIN PSYCHIATR 2006;19 (6):631-636 [PubMed]
  • Helzer JE, van den Brink W, Guth SE, Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V?. ADDICTION 2006;101 (Suppl. 1):17-22 [PubMed]
  • Hogen Esch AJ, van der Heide S, van den Brink W, van Ree JM, Bruynzeel DP, Coenraads PJ, Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). CONTACT DERMATITIS 2006;54 (1):42-49 [PubMed]
  • Jager G. Functional MRI Studies in Human Ecstasy and Cannabis Users. Utrecht: s.n.; 2006. 128p. ISBN 978-90-393-4366-1 Proefschrift UMC Utrecht, RMI. (Promotor(s): Kahn RS, van den Brink W, van Ree JM; copromotor(s): Ramsey NF)
  • Jager G, Kahn RS, van den Brink W, van Ree JM, Ramsey NF, Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. PSYCHOPHARMACOLOGY 2006;185 (3):358-368 [PubMed]
  • Klous MG, Lee WC, van den Brink W, van Ree JM, Beijnen JH, Volatilisation of diacetylmorphine: in vitro simulation of 'chasing the dragon'. PHARMAZIE 2006;61 (5):438-445 [PubMed]
  • Klous MG, Lee W, Hillebrand MJX, van den Brink W, van Ree JM, Beijnen JH, Analysis of diacetylmorphine, caffeine, and degradation products after volatilization of pharmaceutical heroin for inhalation. J ANAL TOXICOL 2006;30 (1):6-13 [PubMed]
  • Langeland W, van den Brink W. Psychiatrische Komorbidität bei traumatisierten Suchtpatienten in: Kraus M, Schäfer I, editors. Trauma und Sucht. Konzepte - Diagnostik - Behandlung. S.l.: Klett-Cotta; 2006., p. 93-108
  • Marissen MAE, Franken IHA, Waters AJ, Blanken P, van den Brink W, Hendriks VM, Attentional bias predicts heroin relapse following treatment. ADDICTION 2006;101 (9):1306-1312 [PubMed]
  • Marquenie LA, Schadé A, van Balkom AJLM, Koeter M, Frenken S, van den Brink W, van Dyck R, Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study. ALCOHOL ALCOHOLISM 2006;41 (2):168-173 [PubMed]
  • Nabitz U, Oudejans S, van den Brink W, Vis C, Wat vindt de Nederlandse bevolking van de verslavingszorg? Een vergelijking van de resultaten uit 1996, 1999, 2002 en 2005. TIJDSCHR GEZONDHEIDSWET 2006;84 (2):100-108
  • Nabitz UW. Quality management in health care. Empirical studies in addiction treatment services aligned to the EFQM excellence model. S.l.: s.n.; 2006. 285p. ISBN 9789064640438 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Walburg JA; copromotor(s): )
  • Ooteman W. Psychobiological pathways to alcohol craving and their relevance for patient-treatment matching. S.l.: s.n.; 2006. 189p. ISBN 9789090207520 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Verheul R; copromotor(s): Koeter MWJ, Schippers GM)
  • Ooteman W, Koeter M, Verheul R, Schippers G, van den Brink W, Development and validation of the Amsterdam Motives for Drinking Scale (AMDS): an attempt to distinguish relief and reward drinkers. ALCOHOL ALCOHOLISM 2006;41 (3):284-292 [PubMed]
  • Ooteman W, Koeter MWJ, Vserheul R, Schippers GM, van den Brink W, Measuring craving: an attempt to connect subjective craving with cue reactivity. ALCOHOL CLIN EXP RES 2006;30 (1):57-69 [PubMed]
  • Philipse MWG, Koeter MWJ, van der Staak CPF, van den Brink W, Static and dynamic patient characteristics as predictors of criminal recidivism: A prospective study in a Dutch forensic psychiatric sample. LAW HUMAN BEHAV 2006;30 (3):309-327 [PubMed]
  • Reneman L, de Win MML, van den Brink W, Booij J, den Heeten GJ, Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J PSYCHOPHARMACOL 2006;20 (2):164-175 [PubMed]
  • Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O, Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J PSYCHOPHARMACOL 2006;20 (3):389-399 [PubMed]
  • Rook EJ, Huitema ADR, van den Brink W, Hillebrand MJX, van Ree JM, Beijnen JH, Screening for illicit heroin use in patients in a heroin-assisted treatment program. J ANAL TOXICOL 2006;30 (6):390-394 [PubMed]
  • Rook EJ, Huitema ADR, van den Brink W, van Ree JM, Beijnen JH, Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. CURR CLIN PHARMACOL 2006;1 (1):109-118 [PubMed]
  • Rook EJ, Huitema ADR, van den Brink W, van Ree JM, Beijnen JH, Population pharmacokinetics of heroin and its major metabolites. CLIN PHARMACOKINET 2006;45 (4):401-417 [PubMed]
  • Rook EJ, van Ree JM, van den Brink W, Hillebrand MJX, Huitema ADR, Hendriks VM, Beijnen JH, Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. BASIC CLIN PHARMACOL 2006;98 (1):86-96 [PubMed]
  • Rook EJ, van Zanten AP, van den Brink W, van Ree JM, Beijnen JH, Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. DRUG ALCOHOL DEPEN 2006;85 (3):185-190 [PubMed]
  • Roozen HG, de Waart R, van der Windt DAWM, van den Brink W, de Jong CAJ, Kerkhof AJFM, A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence. EUR NEUROPSYCHOPHARM 2006;16 (5):311-323 [PubMed]
  • Storosum JG, Wohlfarth T, Gispen-de Wied CC, Linszen DH, Gersons BPR, van Zwieten BJ, van den Brink W, Suicide risk in placebo-controlled trials of bipolar disorder - Dr Storosum and colleagues reply. AM J PSYCHIAT 2006;163 (2):329
  • van den Brink W, Hoe schadelijk zijn softdrugs?. JUSTIT VERKENNINGEN 2006;32 (1):72-89
  • van den Brink W. Stoornissen in het gebruik van middelen in: Pepplinkhuizen L, editor. Het psychiatrisch formularium. S.l.: Bohn Stafleu Van Loghum; 2006., p. 62-75
  • van den Brink W. Verslaving in: Vlaes L, editor. Tot de puzzel past. S.l.: s.n.; 2006., p. 93-107
  • van den Brink W, Verslaving: een chronisch recidiverende hersenziekte. JUSTIT VERKENNINGEN 2006;32 (8):59-75
  • van den Brink W, Haasen C, Evidenced-based treatment of opioid-dependent patients. CAN J PSYCHIAT 2006;51 (10):635-646 [PubMed]
  • van den Brink W, Malesevic T, van Laere IRAL. Verslaving in: Achilles RA, Beerthuis RJ, van Ewijk WM, editors. Handboek Spoedeisende Psychiatrie. S.l.: s.n.; 2006., p. 347-365
  • van den Brink W, Montgomery SA, van Ree JM, van Zwieten-Boot BJ, ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders. EUR NEUROPSYCHOPHARM 2006;16 (3):224-230 [PubMed]
  • van der Zanden BP, Dijkgraaf MGW, Blanken P, de Borgie CAJM, van Ree JM, van den Brink W, Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. DRUG ALCOHOL DEPEN 2006;82 (2):111-118 [PubMed]
  • Vreugdenhil C, van den Brink W, Ferdinand R, Wouters L, Doreleijers T, The ability of YSR scales to predict DSM/DISC-C psychiatric disorders among incarcerated male adolescents. EUR CHILD ADOLES PSY 2006;15 (2):88-96 [PubMed]
  • Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D, The COMT val158met polymorphism and brain morphometry in healthy young adults. NEUROSCI LETT 2006;405 (1-2):34-39 [PubMed]

2005

  • Aarsse HR, Nabitz U, van den Brink W. De kwaliteit in de GGZ en de verslavingszorg: waardering door cliënten en bevolking in: Schene AH, Boer F, Heeren TJ, Jaspers JPC, Sabbe B, van Weeghel J, editors. Jaarboek voor psychiatrie en psychotherapie 2005-2006. Houten: Bohn Stafleu Van Loghum; 2005., p. 289-304
  • Blanken P, Hendriks VM, Koeter MWJ, van Ree JM, van den Brink W, Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials. ADDICTION 2005;100 (1):89-95 [PubMed]
  • de Bruijn C, van den Brink W, Validity of the one-criterion threshold for an alcohol abuse diagnosis. AM J PSYCHIAT 2005;162 (12):2400-2400; author reply 2401 [PubMed]
  • de Bruijn C, van den Brink W, de Graaf R, Vollebergh WAM, Alcohol abuse and dependence criteria as predictors of a chronic course of alcohol use disorders in the general population. ALCOHOL ALCOHOLISM 2005;40 (5):441-446 [PubMed]
  • de Bruijn C, van den Brink W, de Graaf R, Vollebergh WAM, The craving withdrawal model for alcoholism: Towards the DSM-V Improving the discriminant validity of alcohol use disorder diagnosis. ALCOHOL ALCOHOLISM 2005;40 (4):314-322 [PubMed]
  • de Bruijn H. The craving withdrawal model for alcoholism. S.l.: s.n.; 2005. 108p. ISBN 90-73637-66-X [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): de Graaf R)
  • de Wildt WAJM, Lehert P, Schippers GM, Nakovics H, Mann K, van den Brink W, Investigating the structure of craving using structural equation modeling in analysis of the obsessive-compulsive drinking scale: a multinational study. ALCOHOL CLIN EXP RES 2005;29 (4):509-516 [PubMed]
  • de Win MML, Habraken JBA, Reneman L, van den Brink W, den Heeten GJ, Booij J, Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. NEUROPSYCHOPHARMACOL 2005;30 (5):996-1005 [PubMed]
  • de Win MML, Jager G, Vervaeke HKE, Schilt T, Reneman L, Booij J, Verhulst FC, den Heeten GJ, Ramsey NF, Korf DJ, van den Brink W, The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. INT J METH PSYCH RES 2005;14 (4):167-185 [PubMed]
  • Dijkgraaf MGW, van der Zanden BP, de Borgie CAJM, Blanken P, van Ree JM, van den Brink W, Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ-BRIT MED J 2005;330 (7503):1297-1300A [PubMed]
  • Dom G, Sabbe B, Hulstijn W, van den Brink W, Substance use disorders and the orbitofrontal cortex - Systematic review of behavioural decision-making and neuroimaging studies. BRIT J PSYCHIAT 2005;187:209-220 [PubMed]
  • Dom G, Sabbe B, Hulstijn W, van den Brink W, Substance use disorders and the orbitofrontal cortex (vol 187, pg 209, 2002). BRIT J PSYCHIAT 2005;187:490
  • Duits N, van Casteren M, van den Brink W, Doreleijers TAH, Risicotaxatie van geweldsrecidive bij jeugdigen. Het belang van items van de Structured Assessment of Violence Risk in Youth bij het klinisch oordeel. TIJDSCHR PSYCHIATR 2005;47 (8):511-518
  • Duits N, van den Brink W, Doreleijers TAH, Inschatting van de kans op geweldsrecidive in het onderzoek pro Justitia van jongeren. Een klinische benadering. TIJDSCHR PSYCHIATR 2005;47 (10):671-678
  • Franken IHA, Booij J, van den Brink W, The role of dopamine in human addiction: From reward to motivated attention. EUR J PHARMACOL 2005;526 (1-3):199-206 [PubMed]
  • Franken IHA, Zijlstra C, Booij J, van den Brink W. Imaging the addicted brain: reward, craving, and cognitive processes in: Wiers RW, Stacy AW, editors. Handbook of Implicit cognition and addiction. London: SAGE Publications; 2005., p. 185-199
  • Goudriaan AE. Self-regulation in pathological gambling and related disorders: a neurocognitive and psychophysiological investigation. S.l.: s.n.; 2005. 195p. ISBN 242224 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): de Beurs E, Oosterlaan J)
  • Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W, Decision making in pathological gambling: A comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. COGNITIVE BRAIN RES 2005;23 (1):137-151 [PubMed]
  • Hendriks VM, Blanken P, van den Brink W, van Ree JM, Heroïne op medisch voorschrift: resultaten na twee jaar en stand van zaken. EPIDEMIOL BULL 2005;40 (3):2-10
  • Klous MG, Huitema ADR, Rook EJ, Hillebrand MJX, Hendriks VM, van den Brink W, Beijnen JH, van Ree JM, Pharmacokinetic comparison of two methods of heroin smoking: 'chasing the dragon' versus the use of a heating device. EUR NEUROPSYCHOPHARM 2005;15 (3):263-269 [PubMed]
  • Klous MG, Rook EJ, Hillebrand MJX, van den Brink W, van Ree JM, Beijnen JH, Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program. J ANAL TOXICOL 2005;29 (6):564-569 [PubMed]
  • Klous MG, van den Brink W, van Ree JM, Beijnen JH, Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. DRUG ALCOHOL DEPEN 2005;80 (3):283-295 [PubMed]
  • Lange TH, van den Brink W, Hanneman PJJ, Antipsychotica bij patiënten met een dubbeldiagnose schizofrenie en middelenmisbruik. Een literatuuroverzicht. TIJDSCHR PSYCHIATR 2005;47 (4):219-228
  • Lange TH, van den Brink W, Hanneman PJJ, Ervaringen met antipsychotica bij een dubbeldiagnose schizofrenie en middelenmisbruik. Een opiniepeiling onder experts. TIJDSCHR PSYCHIATR 2005;47 (4):253-257
  • Marissen MAE. Cue exposure therapy for the treatment of heroin addiction. S.l.: s.n.; 2005. 145p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Hendriks VM, Franken IHA)
  • Marissen MAE, Franken IHA, Blanken P, Hendriks VM, van den Brink W, The relation between social desirability and different measures of heroin craving. J ADDICT DIS 2005;24 (4):91-103 [PubMed]
  • Marissen MAE, Franken IHA, Blanken P, van den Brink W, Hendriks VM, Cure exposure therapy for opiate dependent clients. J SUBST ABUSE 2005;10 (2-3):97-105
  • Nabitz U, van den Brink W, Jansen P, Using concept mapping to design an indicator framework for addiction treatment centres. INT J QUAL HEALTH C 2005;17 (3):193-201 [PubMed]
  • Nabitz U, van den Brink W, Walburg J, A quality framework for addiction treatment programs. ADDICT BEHAV 2005;30 (6):1254-1260 [PubMed]
  • Nabitz U, van den Brink W, Walburg JA, A quality framework for addiction treaatment programmes: results of a concept mapping strategy. SUCHT 2005;51 (3):138-150
  • Ooteman W, Verheul R, Naassila M, Daoust M, Schippers GM, Koeter MWJ, van den Brink W, Patient-treatment matching with anti-craving medications in alcohol-dependent patients: a review on phenotypic, endophenotypic and genetic indicators. J SUBST ABUSE 2005;10 (2-3):75-96
  • Philipse MWG. Predicting criminal recidivism. Emperical studies and clinical practice in forensic psychiatry. S.l.: s.n.; 2005. 188p. ISBN 90-9019246-8 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van der Staak CPF, van den Brink W; copromotor(s): Koeter MWJ)
  • Philipse MWG, Koeter MWJ, van der Staak CPF, van den Brink W, Reliability and discriminant validity of dynamic reoffending risk indicators in forensic clinical practice. CRIM JUSTICE BEHAV 2005;32 (6):643-664
  • Rehm J, Room R, van den Brink W, Jacobi F, Alcohol use disorders in EU countries and Norway: An overview of the epidemiology. EUR NEUROPSYCHOPHARM 2005;15 (4):377-388 [PubMed]
  • Rehm J, Room R, van den Brink W, Kraus L, Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology. EUR NEUROPSYCHOPHARM 2005;15 (4):389-397 [PubMed]
  • Roozen HG. Community reinforcement approach and naltrexone in the treatment of addiction. S.l.: s.n.; 2005. 255p. ISBN 9789090200965 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kerkhof AJFM, van den Brink W; copromotor(s): de Jong CAJ, Schippers GM)
  • Schadé A, Marquenie LA, van Balkom AJLM, Koeter MWJ, de Beurs E, van den Brink W, van Dyck R, The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: A randomized controlled trial. ALCOHOL CLIN EXP RES 2005;29 (5):794-800 [PubMed]
  • Storosum JG, Wohlfarth T, Gispen-de Wied CC, Linszen DH, Gersons BPR, van Zwieten BJ, van den Brink W, Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. AM J PSYCHIAT 2005;162 (4):799-U2 [PubMed]
  • Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJC, Prediction of relapse to frequent heroin use and the role of methadone prescription: An analysis of the Amsterdam Cohort Study among drug users. DRUG ALCOHOL DEPEN 2005;79 (2):231-240 [PubMed]
  • Tjaden BR, Koeter MWJ, van den Brink W, Vertommen H, De invloed van signatuur van de behandelinginstelling op drop-out: een onderzoek bij drie typen verslavingszorginstellingen. TIJDSCHR PSYCHIATR 2005;47 (1):7-17
  • van den Bosch LMC, Koeter MWJ, Stijnen T, Verheul R, van den Brink W, Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. BEHAV RES THER 2005;43 (9):1231-1241 [PubMed]
  • van den Brink W, Depot naltrexon effectief bij alcoholverslaving. NED TIJDSCHR GENEESKD 2005;149 (36):2022-2023
  • van den Brink W, Epidemiology of cocaine and crack: implications for drug policy an d treatment planning. SUCHT 2005;51 (4):196-198
  • van den Brink W. Stoornissen in het gebruik van middelen in: Hengeveld MW, van Balkom AJLM, editors. Leerboek Psychiatrie. Utrecht: De Tijdstroom; 2005., p. 399-418
  • van den Brink W, Verslaving, een chronisch recidiverende hersenziekte. VERSLAVING 2005;1 (1):x-xx
  • van den Brink W, van Woudenberg-van Vilsteren MJT, Njoo KH. Verslavingsproblematiek in: van der Klink JJL, Terluin B, editors. Psychische problemen en werk. Handboek voor een activerende begeleiding door huisarts en bedrijfsarts. Houten: Bohn Stafleu Van Loghum; 2005., p. 397-426
  • van Nimwegen L, de Haan L, van Beveren N, van den Brink W, Linszen D, Adolescence, schizophrenia and drug abuse: a window of vulnerability. ACTA PSYCHIAT SCAND 2005;111 (Suppl. 427):35-42 [PubMed]
  • Verheul R, Lehert P, Geerlings PJ, Koeter MWJ, van den Brink W, Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. PSYCHOPHARMACOLOGY 2005;178 (2-3):167-173 [PubMed]
  • Verheul R, van den Brink W, Causal pathways between substance use disorders and personality pathology. AUST PSYCHOL 2005;40 (2):127-136
  • Zandvliet AS, Huitema ADR, de Jonge ME, den Hoed R, Sparidans RW, Hendriks VM, van den Brink W, van Ree JM, Beijnen JH, Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. BASIC CLIN PHARMACOL 2005;96 (1):71-79 [PubMed]

2004

  • Aarsse HR, van den Brink W, Koeter MWJ, Behandelvoorkeuren, patiëntwaardeering en behandeluitkomst in ggz en verslavingszorg. Een prospectief onderzoek. TIJDSCHR PSYCHIATR 2004;46 (6):347-356
  • Aarsse HR, van den Brink W, Koeter MWJ, Cliëntentevredenheid in de verslavingszorg en de GGZ. Een prospectief onderzoek naar de invloed van cliëntkenmerken op cliënttevredenheid. GEDRAG GEZONDHEID 2004;32 (3):215-228
  • Aarsse R, van den Brink W, Koeter MWJ, Cliënttevredenheid als kwaliteitsindicatoren in de GGZ en de verslavingszorg: mogelijkheden en risico's. KWALITEIT IN BEELD 2004;- (3):12-14
  • Broekman TG, Schippers GM, Koeter MWJ, van den Brink W, Standardized assessment in substance abuse treatment in the Netherlands: the case of the Addiction Severity Index and new developments. J SUBST ABUSE 2004;9 (3-4):147-155
  • Canton WJ. Gerapporteerd... en dan? Een onderzoek naar risicotaxatie, behandeling en recidieven bij personen over wie pro justitia is gerapporteerd. S.l.: s.n.; 2004. 185p. ISBN ? [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Koeter MWJ, van Panhuis PJA)
  • Canton WJ, van der Veer TS, van Panhuis PJA, Verheul R, van den Brink W, De betrouwbaarheid van risicotaxatie in de pro Justitia rapportage. Een onderzoek met behulp van de HKT-30. TIJDSCHR PSYCHIATR 2004;46 (8):537-542
  • Canton WJ, van der Veer TS, van Panhuis PJA, Verheul R, van den Brink W, De voorspellende waarde van risicotaxatie bij de rapportage pro Justitia. Onderzoek naar de HTK-30 en de klinische inschatting. TIJDSCHR PSYCHIATR 2004;46 (8):525-535
  • de Bruijn C, Korzec A, Koerselman F, van den Brink W, Craving and withdrawal as core symptoms of alcohol dependence. J NERV MENT DIS 2004;192 (7):494-502 [PubMed]
  • de Fuentes-Merillas L. Are schratchcards addictive?. S.l.: s.n.; 2004. 132p. ISBN 90-807598-2-1 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Schippers GM; copromotor(s): Koeter MWJ)
  • DeFuentes-Merillas L, Koeter MWJ, Schippers GM, van den Brink W, Temporal stability of pathological scratchcard gambling among adult scratchcard buyers two years later. ADDICTION 2004;99 (1):117-227 [PubMed]
  • de Win MML, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W, Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender. PSYCHOPHARMACOLOGY 2004;173 (3-4):376-382 [PubMed]
  • Dom G, de Wilde B, van den Brink W, Meetinstrumenten bij stoornissen in het gebruik van middelen. TIJDSCHR PSYCHIATR 2004;46 (10):671-674
  • Driessen FMHM. Methadon in Nederland. Organisatie en uitvoering van de methadonverstrekking, situatie van de methadoncliënten, ontwikkeling van deze situatie gedurende twee jaar en effecten van hoge doses methadon. S.l.: s.n.; 2004. 235p. ISBN 90-73259-36-3 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, van Ree JM; copromotor(s): )
  • Franken IHA, Hendriks VM, Stam CJ, van den Brink W, A role for dopamine in the processing of drug cues in heroin dependent patients. EUR NEUROPSYCHOPHARM 2004;14 (6):503-508 [PubMed]
  • Franken IHA, Hulstijn KP, Stam CJ, Hendriks VM, van den Brink W, Two new neurophysiological indices of cocaine craving: evoked brain potentials and cue modulated startle reflex. J PSYCHOPHARMACOL 2004;18 (4):544-+ [PubMed]
  • Franken IHA, Stam CJ, Hendriks VM, van den Brink W, Electroencephalographic power and coherence analyses suggest altered brain function in abstinent male heroin-dependent patients. NEUROPSYCHOBIOLOGY 2004;49 (2):105-110 [PubMed]
  • Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W, Pathological gambling: a comprehensive review of biobehavioral findings. NEUROSCI BIOBEHAV R 2004;28 (2):123-141 [PubMed]
  • Johnson BA, Ait-Daoud N, Aubin HJ, van den Brink W, Guzzetta R, Loewy J, Silverman B, Ehrich E, A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence. ALCOHOL CLIN EXP RES 2004;28 (9):1356-1361 [PubMed]
  • Klous MG. Development of diacetylmorphine preparations for prescription to opioid dependant patients. S.l.: s.n.; 2004. 205p. ISBN 90-393-3836-1 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Beijnen JH, van Ree JM, van den Brink W; copromotor(s): )
  • Klous MG. Development of diacetylmorphine preparations for prescription to opioid dependent patients. S.l.: s.n.; 2004. -p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Beijnen JH, van Ree JM, van den Brink W; copromotor(s): )
  • Klous MG, Nuijen B, van den Brink W, van Ree JM, Beijnen JH, Development and manufacture of diacetylmorphine/caffeine sachets for inhalation via 'chasing the dragon' by heroin addicts. DRUG DEV IND PHARM 2004;30 (7):775-784 [PubMed]
  • Klous MG, Nuijen B, van den Brink W, van Ree JM, Beijnen JH, Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride. PDA J PHARM SCI TECH 2004;58 (6):287-295 [PubMed]
  • Klous MG, Nuijen B, van den Brink W, van Ree JM, Beijnen JH, Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approach. INT J PHARM 2004;285 (1-2):65-75 [PubMed]
  • Korzec A. Confirming alcoholism in drivers under influence. Amsterdam: Prometheus; 2004. 139p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Koeter MWJ)
  • Langeland W, Draijer N, van den Brink W, Psychiatric comorbidity in treatment-seeking alcoholics: The role of childhood trauma and perceived parental dysfunction. ALCOHOL CLIN EXP RES 2004;28 (3):441-447 [PubMed]
  • Langeland W, van den Brink W, Child sexual abuse and substance use disorders: role of psychiatric comorbidity. BRIT J PSYCHIAT 2004;185:353 [PubMed]
  • Langeland W, van den Brink W, Traumatische Erlebnisse in der Kindheit und psychiatrische Komorbidität bei erwachsenen manlichen Alkoholkranken: Empirische Untersuchungsergebnisse und ihre klinische Bedeutung. SUCHTTHERAPIE 2004;5 (3):132-137
  • Langeland W, van den Brink W, Draijer N. Fysieke en seksuele traumatisering in de kindertijd en het ontstaan van alcoholproblemen in: Buisman WR, ea -, editors. Handboek verslaving (losbladig; 37e aanvulling/oktober 2004). Houten: Bohn Stafleu Van Loghum; 2004.
  • Malesevic T, van den Brink W, van HL, Methylfenidaat bij volwassenen met ADHD en een cocaineverslaving. TIJDSCHR PSYCHIATR 2004;46 (3):179-183
  • Philipse MWG, Koeter MWJ, van den Brink W, van der Staak CPF, The structural coherence of clinically derived dynamic indicators of reoffending risk. CRIM BEHAV MENT HEAL 2004;14 (4):263-279 [PubMed]
  • Rook EJ. Pharmacokinetics and pharmacodynamics of diacetylmorphine in opioid dependant patients. S.l.: s.n.; 2004. 206p. ISBN 90-6464-7992 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van Ree JM, Beijnen JH, van den Brink W; copromotor(s): )
  • Rook EJ. Pharmacokinetics and pharmacodynamics of diacetyl morphine in opioid dependent patients. S.l.: s.n.; 2004. -p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van Ree JM, Beijnen JH, van den Brink W; copromotor(s): )
  • Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, de Jong CAJ, Kerkhof AJFM, A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. DRUG ALCOHOL DEPEN 2004;74 (1):1-13 [PubMed]
  • Schadé A, Marquenie LA, van Balkom AJLM, Koeter MWJ, de Beurs E, van den Brink W, van Dyck R, Alcohol-dependent patients with comorbid phobic disorders: A comparison between comorbid patients, pure alcohol-dependent and pure phobic patients. ALCOHOL ALCOHOLISM 2004;39 (3):241-246 [PubMed]
  • Schippers GM, Broekman TG, Koeter MWJ, van den Brink W, The addiction severity index as a first-generation instrument: commentary on 'studies of the reliability and validity of the ASI' by Makela. ADDICTION 2004;99:416-417
  • Storosum JG, Elferink AJA, van Zwieten BJ, van den Brink W, Huyser J, Natural course and placebo response in short-term, placebo-controlled studies in major depression: A meta-analysis of published and non-published studies. PHARMACOPSYCHIATRY 2004;37 (1):32-36 [PubMed]
  • Storosum JG, Fouwels A , Gispen-de Wied CC, Wohlfarth T, van Zwieten BJ, van den Brink W, How real are patients in placebo-controlled studies of acute manic episode?. EUR NEUROPSYCHOPHARM 2004;14 (4):319-323 [PubMed]
  • Tjaden BR. De invloed van etniciteit, waarden en normen en behandelvisie op de klinische behandeling van verslaafden. S.l.: s.n.; 2004. 114p. ISBN 90-9018555-0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, Vertommen H; copromotor(s): Koeter MWJ)
  • Tjaden BR, Koeter MWJ, Vertommen H, van den Brink W, Verschillen in culturele waarden en normen tussen client en hulpverlener. CULTUUR MIGRATIE GEZONDHEID 2004;1 (1):16-34
  • Tjaden BR, van den Brink W, Vertommen H, Verslavingszorg en drop-out. Achtergrond en perspectieven. TIJDSCHR ALCOHOL DRUGS 2004;25 (3):113-125
  • van Amsterdam JGC, Opperhuizen A, van den Brink W, Cannabis als risicofactor van schizofrenie. TIJDSCHR PSYCHIATR 2004;46 (8):515-524
  • van den Brink W, Epidemiologie van verslaving en de rol van de huisarts. COBO-BULLETIN 2004;- (1):3-9
  • van den Brink W, Welke medicamenteuze behandeling werkt het ebst bij welke roker?. NED TIJDSCHR GENEESKD 2004;148 (34):1703
  • van den Brink W, Blanken P, Hendriks VM, Authors' reply on 'Prescription of heroin to treatment resistant heroin addicts'. BMJ-BRIT MED J 2004;328:229
  • van den Brink W, Ooteman W, Are there different sorts of alcoholics?. ALCOSCOPE 2004;6 (2):8-12
  • van den Brink W, Pelc I, Optimising tteatment outcome with acamprosate in daily practice. DRUGS THER PERSPECT 2004;3 (1):2
  • van den Brink W, Verheul R, Lehert PH, Geerlings PJ, Koeter MWJ, Predictors of acamprosate efficacy in the treatment of alcohol dependence: results from a pooled analysis of 7 European trials. DRUGS THER PERSPECT 2004;3 (1):14-19
  • Verheul R, van den Brink W. Comorbidty of personality disorders and substance use in disorders in: Kranzler HR, Tinsley JA, editors. Dual diagnosis and psychiatric treatment. Substance abuse and comorbid disorders. Second edition. New York, Basel: Marcel Dekker, Inc; 2004., p. 261-316
  • Vreugdenhil C, Doreleijers TAH, Vermeiren R, Wouters LFJM, van den Brink W, Psychiatric disorders in a representative sample of incarcerated boys in the Netherlands. J AM ACAD CHILD PSY 2004;43 (1):97-104 [PubMed]
  • Vreugdenhil C, Vermeiren R, Wouters LFJM, Doreleijers TAH, van den Brink W, Psychotic symptoms among male adolescent detainees in The Netherlands. SCHIZOPHRENIA BULL 2004;30 (1):73-86 [PubMed]
  • Wohlfarth T, Storosum JG, Elferink AJA, van Zwieten BJ, Fouwels A , van den Brink W, Response to tricyclic antidepressants: independent of gender?. AM J PSYCHIAT 2004;161 (2):370-372 [PubMed]

2003

  • Aarsse HR. De betekenis van cliënttevredenheid als indicator voor kwaliteit van zorg. S.l.: s.n.; 2003. 127p. ISBN 90 5170 759 2 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Koeter MWJ)
  • Bammer G, van den Brink W, Gschwend P, Hendriks V, Rehm J, What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?. DRUG ALCOHOL REV 2003;22 (3):363-371 [PubMed]
  • Buster MCA. Prevalence morbidity and mortality among heroin users and methadone patients. S.l.: s.n.; 2003. 181p. ISBN 90 5348 110 9 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): )
  • de Bruijn H, Korzec A, Arndt T, van den Brink W, The discriminant validity of alcohol use disorder in well-functioning men with hazardous alcohol use. EUR ADDICT RES 2003;9 (4):182-187 [PubMed]
  • Duits N, Harkink J, van den Brink W, Doreleijers T, De relatie tussen het advies uit de rapportage Pro Justitia van jeugdigen en het vonnis van de rechtbank. TIJDSCHR FAMILIE JEUGDRECHT 2003;7/8:157-163
  • Duits N, van den Brink W, Doreleijers T, Bruikbaarheid belicht - Een onderzoek onder gebruikers van de Pro Justitia rapportage van jeugdigen. MGV: MAANDBL GEEST VOLKSGEZOND 2003;58:91-103
  • Duits N, van den Brink W, Doreleijers T, Bruikbaarheid nogmaals belicht - De Pro Justitia rapportage van jeugdigen in de ogen van de rapporteurs. MGV: MAANDBL GEEST VOLKSGEZOND 2003;58:104-116
  • Duits N, van den Brink W, Doreleijers TAH. De gebruikswaarde van de pro justitia rapportage van jeugdigen in: Oei TI, Groenhuijsen MS, editors. Actuele ontwikkelingen in de forensische psychiatrie. Deventer: Kluwer; 2003.
  • Franken IHA. Cognitive and neuropsychopharmacological processes in human drug craving. S.l.: s.n.; 2003. 122p. ISBN 90-9016824-9 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Hendriks VM, Stam CJ)
  • Franken IHA, Stam CJ, Hendriks VM, van den Brink W, Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. PSYCHOPHARMACOLOGY 2003;170 (2):205-212 [PubMed]
  • Goppel MA, van den Brink W, van Ree JM, 'Medicamenteuze interventies bij drugverslaving'; een advies van de Gezondheidsraad. NED TIJDSCHR GENEESKD 2003;147 (34):1637-1640 [PubMed]
  • Goppel M, van den Brink W, van Ree JM. 'Medicamenteuze interventies bij drugverslaving'; een advies van de Gezondheidsraad in: Buisman WR, Casselman J, Majoor LBJ, Schippers GM, Silvis J, Walburg JA, editors. Handboek verslaving. Houten: Bohn Stafleu Van Loghum; 2003.
  • Havenaar JM, de Wilde EJ, van den Bout J, Drottz-Sjöberg BM, van den Brink W, Perception of risk and subjective health among victims of the Chernobyl disaster. SOC SCI MED 2003;56 (3):569-572 [PubMed]
  • Hendriks VM, van den Brink W, Blanken P, Koeter MWJ, van Zwieten BJ, van Ree JM, Heroine en methadon op medisch voorschrift voor chronisch, therapieresistente heroineverslaafden: twee gerandomiseerde studies. NED TIJDSCHR GENEESKD 2003;147 (42):2065-2071
  • Hogen Esch AJ, van den Brink W, Bruynzeel DP, Coenraads PJ, Contactallergie voor heroine: een nieuwe beroepsdermatose?. NED TIJDSCHR DERMATOL VENEREOL 2003;ahead of print
  • Langeland W. Childhood trauma in treated alcoholics. Prevalence and relevance for clinical impairment. S.l.: s.n.; 2003. 192p. ISBN 90-6464-569-8 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): )
  • Langeland W, Draijer N, van den Brink W, Assessment of lifetime physical and sexual abuse in treated alcoholics Validity of the Addiction Severity Index. ADDICT BEHAV 2003;28 (5):871-881 [PubMed]
  • Marquenie LA. The comorbidity of alcohol dependence and phobic disorders: origin, course and expectancies. S.l.: s.n.; 2003. 111p. ISBN 90-5669-076-0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van Balkom A, van den Brink W, van Dyck R; copromotor(s): )
  • Reneman L, Booij J, den Heeten GJ, van den Brink W. Beeldvormend onderzoek naar de mogelijke neurotoxiciteit van ecstasy (MDMA) (Hfdst 6) in: Schene AH, de Boer F, Heeren TJ, Henselmans HWJ, Sabbe B, van Weeghel J, editors. Jaarboek voor psychiatrie en psychotherapie 2003-2004. Houten/Mechelen: Bohn Stafleu Van Loghum; 2003., p. 86-102
  • Rinne T, de Kloet ER, Wouters L, Goekoop JG, de Rijk RH, van den Brink W, Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse. NEUROPSYCHOPHARMACOL 2003;28 (1):126-132 [PubMed]
  • Roozen HG, Kerkhof AJFM, van den Brink W, Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: Effect on addictive behaviors and the predictive value of psychiatric comorbidity. EUR ADDICT RES 2003;9 (2):53-58 [PubMed]
  • Schadé AC. The treatment of alcohol-dependent patients with a comorbid phobic disorders. S.l.: s.n.; 2003. 140p. ISBN 90-5669-075-2 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van Dyck R, van den Brink W; copromotor(s): van Balkom AJLM)
  • Schadé A, Marquenie LA, van Balkom AJLM, de Beurs E, van Dyck R, van den Brink W, Do comorbid anxiety disorders in alcohol-dependent patients need specific treatment to prevent relapse?. ALCOHOL ALCOHOLISM 2003;38 (3):255-262 [PubMed]
  • Storosum JG, van Zwieten BJ, Wohlfarth T, de Haan L, Khan A, van den Brink W, Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia. ARCH GEN PSYCHIAT 2003;60 (4):365-368 [PubMed]
  • Tjaden BR, Spoek AM, Koeter MWJ, van den Brink W, Allochtonen en autochtonen in de klinische verslavingszorg: Acceptatie van het behandelaanbod en vroegtijdige beeindiging van de behandeling. MGV: MAANDBL GEEST VOLKSGEZOND 2003;58:461-471
  • van den Bosch LMC. Borderline personality disorder, substance abuse, and dialectical behavior therapy. S.l.: s.n.; 2003. 184p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W; copromotor(s): Verheul R)
  • van den Bosch LMC, Verheul R, Langeland W, van den Brink W, Trauma, dissociation, and posttraumatic stress disorder in female borderline patients with and without substance abuse problems. AUST NZ J PSYCHIAT 2003;37 (5):549-555 [PubMed]
  • van den Bosch LMC, Verheul R, Schippers GM, van den Brink W. Dialectical behavior therapy of borderline patients with and without substance use problems: implementation and long term effects in: Carra G, Clerici M, editors. Dual diagnosis: filling the gap. Paris: John Libbey Eurotext; 2003.
  • van den Brink W, [Drug Use and Addiction: past - present - future] - Deutsch. SUCHTTHERAPIE 2003;4:89-92
  • van den Brink W, Mogelijk is er een oorzakelijk verband tussen cannabisgebruik en schizofrenie. NED TIJDSCHR GENEESKD 2003;147 (17):828-829
  • van den Brink W. New treatment options for heroin dependent patients in the netherlands in: Waal H, Haga E, editors. Maintenance Treatment of Heroin Addiction - evidence at the crossroads. Oslo: Cappelen Akademisk Forlag; 2003.
  • van den Brink W, Phase IV studies of acamprosate: what do they tell us?. ALCOSCOPE 2003;6 (1):7
  • van den Brink W, Science-based practice for methadone treatment: another step forward. SOZ PRAVENTIV MED 2003;48 (Suppl. 1):S15-S16 [PubMed]
  • van den Brink W, The role of psychosocial interventions in the pharmacological treatment of alcohol dependence. DRUGS THER PERSPECT 2003;2 (1):16-21
  • van den Brink W, Goppel M, van Ree JM, Management of opioid dependence. CURR OPIN PSYCHIATR 2003;16 (3):297-304
  • van den Brink W, Hendriks VM, Blanken P, Koeter MWJ, van Zwieten BJ, van Ree JM, Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ-BRIT MED J 2003;327 (7410):310-316 [PubMed]
  • van den Brink W, van Ree JM, Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials (vol 327, pg 310, 2003). BMJ-BRIT MED J 2003;327 (7417):724
  • van den Brink W, van Ree JM, Pharmacological treatments for heroin and cocaine addiction. EUR NEUROPSYCHOPHARM 2003;13 (6):476-487 [PubMed]
  • Verheul R, van den Bosch LMC, Koeter MWJ, de Ridder MAJ, Stijnen T, van den Brink W, Dialectical behaviour therapy for women with borderline personality disorder - 12-month, randomised clinical trial in The Netherlands. BRIT J PSYCHIAT 2003;182:135-140 [PubMed]
  • Vreugdenhil C. Psychiatric disorders among incarcerated male adolescents in the Netherlands. S.l.: s.n.; 2003. 211p. ISBN 90-9017411-7 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Doreleijers TAH, van den Brink W; copromotor(s): Vermeiren R)
  • Vreugdenhil C, van den Brink W, Wouters LFJM, Doreleijers TAH, Substance use, substance use disorders, and comorbidity patterns in a representative sample of incarcerated male Dutch adolescents. J NERV MENT DIS 2003;191 (6):372-378 [PubMed]
  • Wohlfarth TD, van den Brink W, Winkel FW, ter Smitten M, Screening for posttraumatic stress disorder: An evaluation of two self-report scales among crime victims. PSYCHOL ASSESSMENT 2003;15 (1):101-109 [PubMed]

2002

  • Aarsse R, van den Brink W. Cliëntsatisfactie in de geestelijke gezondheidszorg en de verslavingszorg. Een prospectief onderzoek naar determinanten en de relatie met de behandeluitkomst. Amsterdam: AIAR; 2002. -p. ISBN 90-807598-1-3
  • Buster MCA, van Brussel GHA, van den Brink W, An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. ADDICTION 2002;97 (8):993-1001 [PubMed]
  • Buster MCA, van den Brink W. Het schatten van deels verborgen populaties: heroïneverslaafden in Amsterdam in: Bouter LM, Rosendaal FR, editors. Dwalingen in de methodologie. Een bundel artkelen uit het Nederlands Tijdschrift voor Geneeskunde. Amsterdam: NTvG; 2002., p. 87-89
  • Buster M, Rook L, van Brussel GHA, van Ree J, van den Brink W, Chasing the dragon, related to the impaired lung function among heroin users. DRUG ALCOHOL DEPEN 2002;68 (2):221-228 [PubMed]
  • de Bruyn HC, Korzec A, van den Brink W. Behandeling van alcoholisme: maatwerk in: Bakker A, Korzec A, editors. De gecompliceerde kliniek 2003. Als protocollen en richtlijnen tekortschieten. Amsterdam: Benecke N.I.; 2002., p. 73-86
  • de Wildt WAJM, Schippers GM, van den Brink W, Potgieter AS, Deckers F, Bets D, Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?. ALCOHOL ALCOHOLISM 2002;37 (4):375-382 [PubMed]
  • Fischer B, Rehm J, Kirst M, Casas M, Hall W, Krausz M, Metrebian N, Reggers J, Uchtenhagen A, van den Brink W, van Ree JM, Heroin-assisted treatment as a response to the public health problem of opiate dependence. EUR J PUBLIC HEALTH 2002;12 (3):228-234 [PubMed]
  • Franken IHA, Hendriksa VM, van den Brink W, Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. ADDICT BEHAV 2002;27 (5):675-685 [PubMed]
  • Langeland W, Draijer N, van den Brink W, Trauma and dissociation in treatment-seeking alcoholics: Towards a resolution of inconsistent findings. COMPR PSYCHIAT 2002;43 (3):195-203 [PubMed]
  • Langeland W, van den Brink W, Draijer N, Trauma, trauma-related distress, and perceived parental dysfunction: Associations with severity of drinking problems in treated alcoholics. J NERV MENT DIS 2002;190 (5):337-340 [PubMed]
  • Reneman L, Booij J, den Heeten GJ, van den Brink W, Effects of MDMA (ecstasy) use and abstention on serotonin neurons - Reply. LANCET 2002;359 (9317):1617-1618
  • Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van den Brink W, Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. PSYCHOPHARMACOLOGY 2002;159 (3):335-340 [PubMed]
  • Reneman L, Booij J, Schmand BA, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W, Korte- en langetermijneffecten van ecstacy op serotonineproducerende hersencellen en het geheugen. NED TIJDSCHR GENEESKD 2002;146 (47):2240-2246
  • Rinne T. The neuro-endocrine scars of of sustained childhood abuse in adult female patients with borderline personality disorder. S.l.: s.n.; 2002. 125p. ISBN 90-9015816-2 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van den Brink W, de Kloet ER; copromotor(s): )
  • Rinne T, de Kloet ER, Wouters L, Goekoop JG, DeRijk RH, van den Brink W, Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. BIOL PSYCHIAT 2002;52 (11):1102-1112 [PubMed]
  • Rinne T, van den Brink W, Wouters L, van Dyck R, SSRI treatment of borderline personality disorder: A randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. AM J PSYCHIAT 2002;159 (12):2048-2054 [PubMed]
  • Roozen HG, de Kan R, van den Brink W, Kerkhof BJFM, Geerlings PJ, Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure. ADDICT BIOL 2002;97 (8):1071-1073 [PubMed]
  • Schippers GM, Geerlings PJ, van den Brink W. Aandacht van huisartsen voor alcoholproblemen in: Elkerbout R, Helsloot E, editors. Verslaving verslaan. S.l.: s.n.; 2002., p. 48-54
  • Storosum JG, van Zwieten BJ, van den Brink W, Gersons BPR, Broekmans AW, Suicide risk in placebo-controlled studies - Dr. Storosum and colleagues reply. AM J PSYCHIAT 2002;159 (4):681
  • van den Bosch LMC, Verheul R, Schippers GM, van den Brink W, Dialectical Behavior Therapy of borderline patients with and without substance use problems - Implementation and long-term effects. ADDICT BEHAV 2002;27 (6):911-923 [PubMed]
  • van den Brink W, Heroingestützte Behandlung von Drogenabhängigen bei medizinischer Indikation: Schlussfolgerungen aus der holländischer Studie. SUCHT 2002;48 (2):77-78
  • van den Brink W. Verslaving: wat moet de huisarts weten? in: Crul-Kelderhuis JEC, Hoornweg J, Vliet Vlieland CW, Zitman FG, editors. Geestelijke gezondheidszorg. Leiden: Boerhaave Commissie; 2002., p. 77-86
  • van den Brink W. Voorwoord in: van den Bosch LMC, Meijer S, editors. Zoeken naar balans. Dialectische gedragstherapie van A tot Z. Lisse: Swets & Zeitlinger; 2002., p. 9-12
  • van den Brink W. Voorwoord in: Elkerbout R, Helsloot E, editors. Verslaving verslaan. S.l.: s.n.; 2002., p. 7
  • van den Brink W. Woord vooraf in: Korf DJj, Nabben T, Benschop A, editors. Antenne 2001. Trends in alcohol, tabak, drugs en gokken bij jonge Amsterdammers. Amsterdam: Rozenberg; 2002., p. 9-10
  • van den Brink W, Geerlings PJ, Behandeling van verslaving en zorg voor verslaafden. CAH BIO-WET MAATSCH 2002;21 (2):45-55
  • van der Veer TS, Canton WJ, Verheul R, Gons E, van den Brink W, "Gerapporteerd en dan...?": een visie van de rechterlijke macht op de kwaliteit van de ambulante pro justitia rapportage en het belang ervan voor de rechtsgang. PROCES 2002;81 (9-10):146-151
  • Wohlfarth T, Winkel FW, van den Brink W, Identifying crime victims who are at high risk for post traumatic stress disorder: developing a practical referral instrument. ACTA PSYCHIAT SCAND 2002;105 (6):451-460 [PubMed]

2001

  • Buster MC, van Brussel GH, van den Brink W, Estimating the number of opiate users in amsterdam by capture-recapture: the importance of case definition. EUR J EPIDEMIOL 2001;17 (10):935-942 [PubMed]
  • Buster MC, van den Brink W, Dwalingen in de methodologie. XXXI. Het schatten van deels verborgen populaties: heroïneverslaafden in Amsterdam. NED TIJDSCHR GENEESKD 2001;145 (4):164-166 [PubMed]
  • Hendriks VM, van den Brink W, Blanken P, Bosman IJ, van Ree JM, Heroin self-administration by means of 'chasing the dragon': pharmacodynamics and bioavailability of inhaled heroin. EUR NEUROPSYCHOPHARM 2001;11 (3):241-252 [PubMed]
  • Langeland W, van den Brink W, Draijer N, Hartgers C, Sensitivity of the Addiction Severity Index physical and sexual assault items: preliminary findings on gender differences. EUR ADDICT RES 2001;7 (4):193-197 [PubMed]
  • Nabitz U, Severens P, van den Brink W, Jansen P, Improving the EFQM Model: An empirical study on model development and theory building using concept mapping. TOTAL QUAL MANAGE 2001;12 (1):69-81
  • Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W, Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. LANCET 2001;358 (9296):1864-1869 [PubMed]
  • Reneman L, Booij J, Majoie CBLM, van den Brink W, den Heeten GJ, Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. HUM PSYCHOPHARM CLIN 2001;16 (8):579-588 [PubMed]
  • Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J, Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. ARCH GEN PSYCHIAT 2001;58 (10):901-906 [PubMed]
  • Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ, Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. BIOL PSYCHIAT 2001;50 (7):550-554 [PubMed]
  • Rietdijk EA, van den Bosch LM, Verheul R, Koeter MW, van den Brink W, Predicting self-damaging and suicidal behaviors in female borderline patients: reasons for living, coping, and depressive personality disorder. J PERS DISORD 2001;15 (6):512-520 [PubMed]
  • Schrier AC, van den Brink W, Nabarro G, Ouders van minder belang voor de ontwikkeling van de persoonlijkeid van hun kinderen dan leeftijdgenoten? Een kritische besprrekking van de groepsssocialisatietheorie van Harris. TIJDSCHR PSYCHIATR 2001;43 (12):813-817
  • Storosum JG, Elferink AJA, van Zwieten BJ, van den Brink W, Gersons BPR, van Strik R, Broekmans AW, Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study (vol 11, pg 173, 2001). EUR NEUROPSYCHOPHARM 2001;11 (4):325
  • Storosum JG, Elferink AJ, van Zwieten BJ, van den Brink W, Gersons BP, van Strik R, Broekmans AW, Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study. EUR NEUROPSYCHOPHARM 2001;11 (2):173-180 [PubMed]
  • Storosum JG, van Zwieten BJ, van den Brink W, Gersons BP, Broekmans AW, Suicide risk in placebo-controlled studies of major depression. AM J PSYCHIAT 2001;158 (8):1271-1275 [PubMed]
  • Storosum JG, van Zwieten BJ, Vermeulen HD, Wohlfarth T, van den Brink W, Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues. EUR PSYCHIAT 2001;16 (6):327-335 [PubMed]
  • van den Bosch LM, Verheul R, van den Brink W, Substance abuse in borderline personality disorder: clinical and etiological correlates. J PERS DISORD 2001;15 (5):416-424 [PubMed]
  • Wohlfarth T, Winkel FW, Ybema JF, van den Brink W, The relationship between socio-economic inequality and criminal victimisation: a prospective study. SOC PSYCH PSYCH EPID 2001;36 (7):361-370 [PubMed]

2000

  • Reneman L, Booij J, Schmand B, van den Brink W, Gunning B, Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. PSYCHOPHARMACOLOGY 2000;148 (3):322-324 [PubMed]
  • Rinne T, Westenberg HG, den Boer JA, van den Brink W, Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. BIOL PSYCHIAT 2000;47 (6):548-556 [PubMed]
  • Verheul R, van den Brink W, The role of personality pathology in the aetiology and treatment of substance use disorders. CURR OPIN PSYCHIATR 2000;13 (2):163-169
  • Wiers RW, Hartgers C, van den Brink W, Gunning WB, Sergeant JA, A confirmatory analysis of the hierarchical structure of positive and negative dose-related alcohol expectancies in alcoholics and the associations with family history of alcoholism. J STUD ALCOHOL 2000;61 (1):177-186 [PubMed]

1999

  • Boersma F, van den Brink W, Deeg DJ, Eefsting JA, van Tilburg W, Survival in a population-based cohort of dementia patients: predictors and causes of mortality. INT J GERIATR PSYCH 1999;14 (9):748-753 [PubMed]
  • de Vos JW, Ufkes JG, van den Brink W, van Brussel GH, de Wolff FA, Craving patterns in methadone maintenance treatment with dextromoramide as adjuvant. ADDICT BEHAV 1999;24 (5):707-713 [PubMed]
  • Tiemens BG, Ormel J, Jenner JA, van der Meer K, van Os TW, van den Brink RH, Smit A, van den Brink W, Training primary-care physicians to recognize, diagnose and manage depression: does it improve patient outcomes?. PSYCHOL MED 1999;29 (4):833-845 [PubMed]
  • van den Brink W, Dimensional models and neurobiology of personality disorders. ACTA NEUROPSYCHIATR 1999;11 (1):1-4 [PubMed]
  • van den Brink W, Hendriks VM, van Ree JM, Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands. J DRUG ISSUES 1999;29:587-607
  • van Os TW, Ormel J, van den Brink RH, Jenner JA, van der Meer K, Tiemens BG, van der Doorn W, Smit A, van den Brink W, Training primary care physicians improves the management of depression. GEN HOSP PSYCHIAT 1999;21 (3):168-176 [PubMed]
  • Verheul R, van den Brink W, Geerlings P, A three-pathway psychobiological model of craving for alcohol. ALCOHOL ALCOHOLISM 1999;34 (2):197-222 [PubMed]
  • Verheul R, van den Brink W, Koeter MW, Hartgers C, Antisocial alcoholic patients show as much improvement at 14-month follow-up as non-antisocial alcoholic patients. AM J ADDICTION 1999;8 (1):24-33 [PubMed]

1998

  • Bergman AJ, van den Berg IE, Brink W, Poll-The BT, Ploos van Amstel JK, Berger R, Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries. HUM MUTAT 1998;12 (1):19-26 [PubMed]
  • Boersma F, Eefsting JA, van den Brink W, Koeter M, van Tilburg W, Prevalence of dementia in a rural Netherlands population and the influence of DSM-III-R and CAMDEX criteria for the prevalence of mild and more severe forms. J CLIN EPIDEMIOL 1998;51 (3):189-197 [PubMed]
  • Ustun B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottler L, Gogus A, Mavreas V, Peters L, Pull C, Saunders J, Smeets R, Stipec MR, Vrasti MRS, Hasin D, Room R, van den Brink W, Regier D, Blaine J, Grant BF, Sartorius N, WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: Overview of methods and results (vol 47, pg 161, 1997). DRUG ALCOHOL DEPEN 1998;50 (2):185-186
  • Verheul R, Hartgers C, van den Brink W, Koeter MW, The effect of sampling, diagnostic criteria and assessment procedures on the observed prevalence of DSM-III-R personality disorders among treated alcoholics. J STUD ALCOHOL 1998;59 (2):227-236 [PubMed]
  • Verheul R, van den Brink W, Hartgers C, Personality disorders predict relapse in alcoholic patients. ADDICT BEHAV 1998;23 (6):869-882 [PubMed]
  • Verheul R, van den Brink W, Koeter MW, Temporal stability of diagnostic criteria for antisocial personality disorder in male alcohol dependent patients. J PERS DISORD 1998;12 (4):316-331 [PubMed]
  • Wohlfarth T, van den Brink W, Social class and substance use disorders: the value of social class as distinct from socioeconomic status. SOC SCI MED 1998;47 (1):51-58 [PubMed]

1997

  • Havenaar J, Rumyantzeva G, Kasyanenko A, Kaasjager K, Westermann A, van den Brink W, van den Bout J, Savelkoul J, Health effects of the Chernobyl disaster: illness or illness behavior? A comparative general health survey in two former Soviet regions. ENVIRON HEALTH PERSP 1997;105 (Suppl. 6):1533-1537 [PubMed]

1996

  • de Vos JW, Ufkes JG, van Brussel GH, van den Brink W, Craving despite extremely high methadone dosage. DRUG ALCOHOL DEPEN 1996;40 (3):181-184 [PubMed]

1995

  • de Vos JW, Geerlings PJ, van den Brink W, Ufkes JG, van Wilgenburg H, Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. EUR J CLIN PHARMACOL 1995;48 (5):361-366 [PubMed]

1990

  • van den Brink W, van der Loos C, Volkers H, Lauwen R, van den Berg F, Houthoff HJ, Das PK, Combined beta-galactosidase and immunogold/silver staining for immunohistochemistry and DNA in situ hybridization. J HISTOCHEM CYTOCHEM 1990;38 (3):325-329 [PubMed]

1987

  • Sprangers MAG, van den Brink W, van Heerden J, Hoogstraten J, A constructive replication of White's alleged refutation of Nisbett and Wilson and of Bem: Limitations on verbal reports of internal events. J EXP SOC PSYCHOL 1987;23:301-310